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Resumo 
 
Ácidos biliares (ABs) são derivados do colesterol sintetizados no fígado, cuja função é 
solubilizar lípidos durante a digestão. Este grupo é composto por vários moléculas que variam no 
número e posições dos grupos hidroxilo e no seu grupo terminal. Os ácidos biliares são 
caracterizados consoante a sua hidrofobicidade. 
Os ABs hidrófobos (como o ácido deoxicólico, DCA) são activadores de apoptose tanto 
por via extrínseca, induzindo a activação de receptores de morte, como por via intrínseca, 
promovendo a libertação de factores pro-apoptóticos dos mitocôndrios. Por outro lado, os ABs 
hidrófilos (como os ácidos ursodeoxicólico, UDCA, e tauroursodeoxicólico, TUDCA) são inibidores 
da apoptose, inibindo os eventos acima descritos. No entanto, o mecanismo através do qual os 
ABs induzem respostas antagónicas ainda não está elucidado. Neste trabalho é posta a hipótese 
que a membranas celulares constituem o alvo principal na sinalização pró-apoptótica. 
Adicionalmente, o trabalho segue também três linhas de investigação que tentam esclarecer 
qual o efeito citoprotector dos ABs hidrófilos: 
1) os ABs hidrófilos e hidrófobos interactuam em solução dando origem a um agregado 
misto que é inócuo para as células; 
2) os ABs hidrófilos impedem a partição e interacção dos ABs hidrófobos com 
membranas; 
3) os ABs hidrófilos alteram a dinâmica das membranas celulares impedindo ou 
revertendo possíveis alterações induzidas por ABs hidrófobos. 
Foram utilizados os ABs DCA, UDCA e TUDCA, bem como dois ABs derivados com o 
grupo fluorescente nitro-2-1,3-benzoxadiazol-4yl (NBD), DCA-NBD e UDCA-NBD. 
 
Em primeiro lugar e com o objectivo de testar o comportamento dos derivados de ABs, a 
concentração micelar crítica dos ácidos biliares não marcados foi determinada usando como 
sondas os ABs derivatizados ou Nile Red, uma sonda hidrófoba. Observou-se que tanto os 
derivados de ABs como o Nile Red detectavam micelas de ABs de forma semelhante. No 
entanto, a formação de micelas de ABs foi detectada a concentrações mais baixas quando os ABs 
derivatizados foram utilizados. Isto indica que os ABs derivatizados têm maior afinidade para 
micelas de AB que outras sondas hidrófobas. 
De seguida, o comportamento dos ABs derivatizados foi estudado em solução aquosa. 
Foi observado que os dois derivados de fluorescentes agregavam em solução aquosa a 
concentrações superiores a 2 μM. Provou-se que esta agregação é induzida pelo grupo NBD, o 
que indica que a derivatização, ao retirar à molécula um grupo carregado negativamente, induz 
agregação. Ainda assim, foi observado que ABs hidrófilos (não marcados) interagem com DCA-
NBD na gama de concentrações em que estas moléculas apresentam um efeito citoprotector. 
Utilizando um modelo matemático, foram ajustadas constantes de agregação aos dados de 
fluorescência em função da concentração de DCA-NBD na presença e na ausência de ABs 
Resumo 
 
vi 
 
hidrófilos. O modelo recuperou uma constante de agregação de DCA-NBD com ABs hidrófilos na 
ordem dos 0.002-0.004 μM-1. Estes valores indicam uma interacção muito fraca entre DCA-NBD 
e UDCA ou TUDCA. Tendo em conta que o DCA-NBD é mais susceptível à formação de agregados 
que o DCA, podemos concluir que o efeito citoprotector dos ABs hidrófilos não se deve à 
formação de um complexo inerte hidrófilo/hidrófobo em solução. 
 
A partição dos derivados de ABs para membranas modelo foi também estudada. Para 
isso foram utilizados dois tipos de vesículas compostas apenas por POPC ou por POPC, colesterol 
e PSM. Notou-se que tanto DCA-NBD como UDCA-NBD particionavam de forma análoga para 
vesículas constituídas apenas por POPC e que particionavam com menor eficácia para vesículas 
contendo uma mistura de POPC, colesterol e PSM (mistura lipídica com coexistência de fases 
liquido ordenadas, lo, e desordenadas, ld). A partição de UDCA-NBD e DCA-NBD foi 
dramaticamente afectada pela presença de fases ordenadas. Devido à interacção detectada 
entre DCA-NBD e ABs hidrófilos, a partição do DCA-NBD para vesículas de POPC foi de novo 
analisada após incubar as vesículas com elevadas concentrações de ABs hidrófilos. Foi observado 
que a partição do DCA-NBD não era alterada pela presença de ABs hidrófilos. 
 
O efeito de ABs não marcados nas propriedades biofísicas de sistemas modelo de 
membranas foi também estudado. Neste conjunto de experiências, várias sondas de membrana 
foram incorporadas nas vesículas, cada uma monitorizando uma propriedade biofísica diferente, 
desde fluidez de diferentes regiões ao potencial de membrana. Foi observado que a sonda DPH 
era insensível à presença de ABs mas que a sonda ANEPPDHQ aumentava o seu rendimento 
quântico na presença destas moléculas. Sendo o DPH (uma sonda de fluidez do interior da 
membrana) insensível aos ABS e o ANEPPDHQ (uma sonda mais superficial) sensível aos ABs, 
conclui-se que a possível localização dos ácidos biliares é à superfície da membrana. 
Por outro lado, foi observado que o aumento a concentração de colesterol nas 
membranas não era acompanhado pelo aumento de rigidez na presença de DCA. No entanto, o 
efeito medido não era inibido por ABs hidrofílos. Foi provado que este efeito não era devido à 
remoção de colesterol por DCA, pois a sonda dehidroergosterol, um análogo fluorescente do 
colesterol, não era removido das vesículas pelo AB. Conclui-se portanto que o DCA em 
concentrações submicelares elimina parcialmente a capacidade do colesterol de rigidificar 
membranas. Este efeito não é observado em fase lo. Adicionalmente, foi observado um aumento 
considerável da área superficial de membranas após incubação com DCA. A exposição de 
membranas biológicas ao DCA poderá assim resultar numa alteração significativa das suas 
propriedades biofísicas. 
 
Finalmente, células HEK293 foram incubadas com DCA ou TUDCA ou uma combinação 
dos dois ABs. As células, marcadas anteriormente com ANEPPDHQ, foram analisadas por FLIM 
de modo a estudar o efeito dos ABs in vivo. Foi observado que o tempo de vida da sonda 
ANEPPDHQ diminuía após incubação com os ABs. Estes resultados diferem dos obtidos em 
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sistemas modelo, em que era observado um aumento no tempo de vida desta sonda. Esta 
discrepância pode ser explicada pela presença de diferentes membranas, com diferentes 
composições num sistema vivo, ou por um efeito da activação da via apoptótica nas células. É 
possível que os ABs tenham efeitos diferentes em membranas com composições diferentes, o 
que explicaria a discrepância observada. 
 
Concluindo, neste estudo foi observado que DCA-NBD e UDCA-NBD agregam em solução 
aquosa e que particionam de forma semelhante e preferencial para fases ld. A partição de DCA-
NBD não é afectada por ABs hidrófilos. Através de estudos utilizando sondas de membrana, 
concluiu-se que a posição de ABs em membranas é possivelmente superficial. A observação de 
que o DCA elimina parcialmente a capacidade do colesterol de rigidificar membranas, foi de 
particular importância para a elucidação do mecanismo apoptótico destas moléculas. Este 
poderá assim estar relacionado com uma alteração na organização dos componentes da 
membrana plasmática, nomeadamente a nível da formação/composição de jangadas lipídicas. 
Por último, o efeito dos ABs em células foi estudado e é aparentemente diferente do observado 
em sistemas modelo, indicando que em células vidas, a eliminação parcial do efeito rigidificante 
do colesterol não é o único efeito na estrutura de membranas biológicas resultante da 
incubação com ácidos biliares hidrófobos. 
 
 
Palavras-chave: Espectroscopia de fluorescência, Sistemas modelo de membranas, Apoptose, 
Jangadas lipídicas, Colesterol 
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Summary 
 
Bile acids (BAs) are cholesterol derivates synthetized in the liver of humans. Hydrophobic 
bile acids (BAs) such as deoxycholic acid (DCA) induce cell death via multiple pathways, including 
the extrinsic pathway of apoptosis, dependent on pro-apoptotic receptor activation in the 
plasma membrane, and the intrinsic pathway of apoptosis, involving the release of pro-apoptotic 
factors from mitochondria. In turn, it has been shown that hydrophilic BAs, particularly 
ursodeoxycholic (UDCA) and tauroursodeoxycholic (TUDCA) acids significantly inhibit most of 
these events, thereby preventing apoptosis. Still, the mechanisms by which BAs trigger such 
opposite signaling effects remain unclear. We hypothesize that cellular membranes may 
constitute a determinant primary target for the modulatory effects of BAs during apoptosis. 
In this work, two nitro-2-1,3-benzoxadiazol-4yl (NBD) fluorescent derivatives of DCA and 
UDCA, namely DCA-NBD and UDCA-NBD were studied. Both DCA-NBD and UDCA-NBD interacted 
with micellar and pre-micellar aggregates of the unlabeled molecules. Interestingly, unlabeled 
hydrophilic BAs UDCA and TUDCA interacted weakly with DCA-NBD at pre-micellar 
concentrations. 
In addition, both probes partitioned effectively and in similar extent to model membranes 
(POPC liposomes) and were sensitive to the presence of cholesterol in the membrane. Although 
UDCA and TUDCA interacted with DCA-NBD, these interactions did not change DCA-NBD 
partition properties. 
Unlabeled BAs DCA, UDCA and TUDCA were shown to induce changes in the fluorescence 
properties of superficially-located membrane probes, which indicate a superficial but strong 
interaction with membranes. Lastly, DCA limited to some extent the rigidifying effect of 
cholesterol on the lipid membrane. This effect could not be abrogated by hydrophilic BAs and 
might correlate with the apoptotic effect of hydrophilic BAs on cells. 
Lastly, FLIM was performed on ANEPPDHQ-labeled HEK293 cells with different results than 
in membrane model systems, suggesting that effects on biological membranes are not limited to 
the inhibition of the cholesterol rigidifying effect. 
 
 
Keywords: Fluorescence spectroscopy, Model Membrane systems, Apoptosis, Lipid Rafts, 
Cholesterol 
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1.1. Bile acid function, synthesis and chemistry  
 
Bile acids (BAs) are natural-occurring detergents that solubilize dietary lipids in the intestinal 
tract and in bile [1]. They are a group of amphipathic molecules and the main product of 
cholesterol (Chol) metabolism of humans and other vertebrates [2]. 
The BA group encompasses a great variety of molecules ranging from C27 bile alcohols to 
C27 bile acids and C24 bile acids [2]. This variety can be explained by the evolution of multiple 
metabolic pathways that serve to convert Chol, a poorly soluble lipid, to water-soluble, 
amphipathic molecules [2]. It is accepted that the end products of bile acid synthesis in lower 
vertebrates are the precursors of end products of bile salt biosynthesis in higher vertebrates [3]. 
Humans only possess C24 bile acids, the farthest from Chol within the metabolic pathway. 
Function 
BAs are synthesized in the liver and flow from it, through the bile ducts, into the gallbladder 
where they are stored along with bilirubin, phospholipids, etc. After a meal, gallbladder is 
Figure 1-1 - Enterohepatic circulation of bile acids. After being 
synthesized by hepatocytes, bile acids flow to the gallbladder to 
be stored. After a meal, the gallbladder is emptied and BAs 
reach the small intestine, through the Sphincter of Oddi. BAs 
transit through the small intestine, are absorbed again in the 
terminal ileum as mixed micelles with fatty acids, phospholipids 
and cholesterol, and move through the portal vein to the liver 
were they are mostly recovered. There is some BA spill over 
onto systemic circulation. Adapted from [2] 
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emptied and BAs are released in the small intestine at millimolar concentrations. In these 
conditions BAs aggregate and form mixed micelles with other fats, such as Chol, fatty acids, 
phospholipids, etc. These aggregates are then absorbed in the small intestine ileum and travel 
back to the liver through the portal vein. In the liver, BAs are recovered from mixed micelles and 
the cycle starts again. This process is called enterohepatic circulation (Figure 1-1) [2,4,5]. 
 
Synthesis 
In humans, BAs synthesized from Chol in the liver are named primary. These are 
chenodeoxycholic acid (CDCA, Figure 1-2) and cholic acid (CA) [2]. During entherohepatic cycling, 
primary BAs are exposed to intestinal bacteria enzymes that modify them (e.g., the hydroxyl 
groups can be epimerized, oxidized or removed) to produce secondary BAs, such as deoxycholic 
acid (DCA) and lithocholic acid (LCA) [2]. DCA and LCA are the dehydroxylation products of CA 
and CDCA, respectively [5]. Secondary bile acids can be transformed again by bacteria or by 
hepatocytes to yield tertiary BAs, as ursodeoxycholic acid (UDCA) [5]. Any BA can be conjugated 
with taurine or glycine amino acids to yield even more soluble molecules [5]. For example, UDCA 
can be conjugated with taurine to produce tauroursodexycholic acid (TUDCA). Moreover, BAs 
interact with nuclear receptors and modulate signalling cascades directly adjusting their own 
synthesis, uptake and secretion to the body’s needs [5]. 
Most BAs in human bile are conjugated with either glycine or taurine (2:1 ratio) and the 
quantitative balance is typically 13 CDCA: 12 CA: 7 DCA: 1 UDCA [6]. Human BA pool is an ever-
changing environment, depending on diet, lifestyle, age, daytime, etc. [2,3,5]. 
  
Figure 1-2 - Chemical structure of cholesterol (top) and CDCA, the root C24 bile acid 
(bottom). Major changes are epimerization of C3, reduction of the double bond 
between C5 and C6, C7 hydroxylation, beta-oxidation of 8-carbon side chain to a 5-
carbon chain. Adapted from [2] 
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Chemistry 
BA structure is based on the tetracyclic steroid ring system, inherited from Chol. Attached to 
the ring are hydroxyl (-OH) groups that confer an amphipathic character to the molecule. Human 
BAs differ in number and position of hydroxyl groups as well as in the conjugated amino acid 
(Figure 1-3, Table 1-1). 
They are biologically detergent-like molecules because of their amphipathic nature, 
possessing both hydrophobic and hydrophilic regions (Figure 1-3) [2]. The most used 
classification of BA is their hydrophobicity, which is directly related to the number and position 
of -OH groups [1]. This was derived by reverse-phase High-Performance Liquid Chromatography 
(HPLC) capacity factor, i.e. partition between the octanol stationary phase and an aqueous 
mobile phase [7]. Hydrophobicity followed the sequence DCA>CDCA>CA>UDCA, being DCA the 
most hydrophobic and UDCA the most hydrophilic [1]. Conjugation reduces hydrophobicity but 
the relative hydrophobicity order was the same [1]. 
As carboxylic acids, most bile acids have a pKa of 5, meaning their carboxyl group will be 
deprotonated at physiological pH since intestinal pH is around 7 [3]. Taurine conjugation adds a 
sulphide group that lowers the molecules pKa to ≈1 while glycine conjugation lowers pKa to ≈3, 
improving both acidity and solubilisation ability [3] as BAs are better emulsifiers in their salt form 
[5]. 
  
Figure 1-3 – (A) Chemical structure of typical bile acids. R1-R3 can be either -OH or -H. R4 can be carboxylic acid, 
taurine or glycine aminoacids. (B) Space filling model of a typical conjugated bile salts contrasting the 3 hydroxyl 
groups. The molecule possesses both hydrophobic (left) and hydrophilic (right) sides. Adapted from [2,8] 
A B 
Introduction 
6 
 
 
Table 1-1 - Chemical composition of several bile acids according to Figure 1-3 
Bile acid name Abbrev. R1 R2 R3 R4 
Cholic CA OH OH OH COOH 
Deoxycholic DCA OH H OH COOH 
Chenodeoxycholic CDCA OH OH H COOH 
Ursodeoxycholic UDCA OH OH 
(epimerized) 
H COOH 
Lithocholic LCA OH H H COOH 
Glicocholic GCA OH OH OH CONHCH2COOH 
Taurocholic TCA OH OH OH NHCH2CH2SO3H 
Glicodeoxycholic GDCA OH H OH CONHCH2COOH 
Taurodeoxycholic TDCA OH H OH NHCH2CH2SO3H 
Glicochenodeoxycholic GCDCA OH OH H CONHCH2COOH 
Taurochenodeoxycholic TCDCA OH OH H NHCH2CH2SO3H 
Glicoursodeoxycholic GUDCA OH OH 
(epimerized) 
H CONHCH2COOH 
Tauroursodeoxycholic TUDCA OH OH 
(epimerized) 
H NHCH2CH2SO3H 
 
1.2. Bile acid aggregation 
 
Bile acids were the subject of extensive study in the 70s and 80s due to the discovery of anti-
inflammatory steroid cortisone. Most were readily synthesized by the end of the 70s and their 
chemical properties were studied in numerous papers. The goal was to connect each chemical 
structure to a physico-chemical behavioural difference (BA history reviewed in [3]). 
 
BA do not aggregate as typical amphiphiles 
Classic amphiphiles have a clear separation between hydrophobic and hydrophilic domains 
and aggregates are normally associated so that the hydrophobic part is protected from water 
inside the aggregate, leaving the hydrophilic structure to interact with water [8]. Conversely, BAs 
have a facial structure with a rigid steroid ring separating the hydrophobic and hydrophilic sides 
(Figure 1-3) [8]. Also, the presence of hydroxyl and acidic groups allows for the formation of 
intermolecular hydrogen bonds [8]. Furthermore, the presence of an ionized side chain leads to 
repulsive interactions between BAs [8]. As consequence of their molecular structure, BA 
aggregation in aqueous solutions is quite different from classic amphiphiles because it is driven 
by both the hydrophobic effect and intermolecular hydrogen bonding [8]. Hence, BA aggregation 
and is dependent on the molecular structure of the BA. 
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BA aggregation models 
BA aggregation is temperature, pH and ionic strength dependent [6,9–13]. Likewise, the 
more hydrophobic the BA is, the greater the tendency it has to aggregate [9]. Furthermore, 
conjugated BAs aggregate more easily than unconjugated BAs [6,11].  
When studying the aggregation pattern of amphiphiles, the most important parameter is the 
critical micellar concentration (CMC), which is the concentration at which a solute molecules 
start to form micelles [8]. However, for BAs the CMC is not a clear value, depending on detection 
method [13]. 
In the 1979s, Small devised a model to describe BA aggregation [14] (Figure 1-4A). He 
postulated that BAs exist in aqueous solution in three species, monomer, primary micelles and 
secondary micelles. After reaching a certain concentration, CMC1, monomers, aggregate as a 
consequence of the hydrophobic effect to form primary micelles, which were detectable by light-
scattering. BAs in primary micelles aggregate with their hydrophobic face turned to the centre of 
the aggregate and their hydrophilic side to the outside. Increasing the concentration of BA to the 
CMC2 value, these primary micelles polymerized due to hydrogen bonding leading to a “string-
of-pearls aggregate”, the secondary micelle. 
Small proposed that the hydrophobic effect is the sole force behind aggregation at low BA 
concentration [14]. This model is generally accepted for bile acids aggregation and several 
papers describe bile acid aggregation using a two-phase model [6,10,11,15]. Nevertheless, 
controversy has risen due to the crystallization of a DCA helical micelle which had all 
hydrophobic faces turned outward, facing the solvent, and the polar groups facing the inside, 
resembling an inverted micelle [16] (Figure 1-4B). The thermodynamic rational for this inverted 
micelle is that the hydrogen bonding in the centre of the aggregate outweighs the hydrophobic 
effect [17]. While these two models dispute micellar structures, the idea that only one model is 
able to explain the aggregation behaviour of every BA is perhaps excessively ambitious. 
 
B 
Figure 1-4 - Schematic representations of bile acid aggregates. (A) Primary-secondary hypothesis for BA aggregation 
proposed by Small 1979 [14]. (B) Helical micelle of deoxycholic acid seen from top. Adapted from [8,14] 
A 
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Submicellar aggregation of BAs 
The disparity between recovered CMC values for BAs is due to the small aggregate size. In 
fact, the aggregation number (total number of molecules in the aggregate,     ) of BAs in 
micelles is small (         ) comparing with classic amphiphiles (       ) [6,9]. Actually, 
the aggregation number increases in a concentration-dependent fashion, which means that 
aggregate size is increasing in a stepwise fashion as BA concentration increases [9,10]. Oddly 
enough, the aggregation constant for the formation of an even-numbered aggregated is larger 
than that for a neighbouring odd-numbered aggregate. This means that micelles with an even 
number of molecules are more stable than micelles with an odd number of molecules [9].  
Such low aggregation number render pre-micellar aggregates imperceptible to most 
detection methods, yet, BAs are very likely aggregated at sub-micellar concentrations (in even-
numbered aggregates, Figure 1-5) to better reduce the exposed hydrophobic part. 
 
1.3. Bile acids and apoptosis 
 
When enterohepathic circulation is obstructed, BA concentration in the liver greatly 
increases and cholestasis happens [5]. Although cholestasis can have a myriad of causes, from 
cirrhosis to liver or pancreatic carcinoma, the result is always the same: obstruction of normal 
bile flow, resulting in BA accumulation in the liver [5]. Hepatocyte cellular and mitochondrial 
membranes are in danger of BA-solubilisation and liver damage can be severe if cholestasis is 
left untreated [5]. Interestingly, BA concentration never reaches the levels required for 
membrane solubilisation, remaining well below the CMC. Nevertheless, cell death is the major 
consequence of cholestasis [5]. Only in the 1990s were BAs revealed to induce cell death by 
apoptosis and not by membrane solubilisation [18]. 
  
Figure 1-5 - Schematic representation of different models 
for submicellar aggregates of BAs. Adapted from [8] 
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Apoptosis 
Apoptosis is a programed and ordered cell death; this process is genetically conserved 
throughout evolution and allows for the removal of abnormal growing cells. Apoptosis can be 
induced by drugs, radiation, infection or growth factor deprivation as well as by cytotoxic T cells 
[19]. Major research is being conducted on trying to force malignant cells to enter apoptosis, 
providing a safer and more direct cancer therapy [19–21]. An apoptotic cell suffers various 
transformations: chromatin condensation and DNA hydrolysis, cytoplasmic shrinkage, 
membrane blebbing and, ultimately, the formation of apoptotic vesicles containing organelles 
and parts of the nucleus [20]. These vesicles are phagocytized by macrophages, clearing the 
tissue from debris [20]. 
Apoptosis can be induced by two entangled pathways: the intrinsic and the extrinsic 
pathway (Figure 1-6). Both are heavily dependent on transcription factor p53, a major player in 
deciding cell fate as it enhances the expression of pro-apoptotic proteins Bcl-2-associated X 
Proten (Bax), Bad, Noxa, Puma, Apoptic Protease activating Factor 1 (Apaf-1) and Caspases, a 
family of proteases termed executioners that are at the centre of apoptosis induction [20,22]. 
The intrinsic, or mitochondrial, pathway is a consequence of stresses that converge on 
mitochondria and that can lead to membrane permeabilization, release of apoptogenic proteins, 
specifically cytochrome c, and disruption of the mitochondrial membrane potential [20] (Figure 
1-6). All these changes lead to caspase activation and ultimately cell death [20]. Two pro-
apoptotic proteins Bax and Bad, are greatly linked to apoptosis activation via mitochondria as 
they undergo a conformational change and oligomerize in the mitochondrial membrane. There, 
they form pores, disrupting the mitochondrial membrane potential and releasing cytochrome c 
to the cytosol [20,23–25].  
The extrinsic pathway, or death receptor pathway, is triggered by ligand:death-receptor 
interaction, e.g. Fas-ligand:Fas [26]. This interaction leads to caspase activation which, 
depending on the cell type, might be enough for apoptosis induction (Figure 1-6). For instance, 
in hepatocytes, the mitochondrial pathway needs to endorse the pro-apoptotic signal from 
death-receptors for apoptosis to happen [20]. 
Both pathways lead to cytochrome c release and apoptosome formation. This enormous 
protein complex is essential for apoptosis and it is formed by cytochrome c, Apaf-1 and Caspase-
9 [26] (Figure 1-6). 
Apoptosis can be stopped if pro-survival signals can stop the apoptotic signal. Pro-survival 
signals include growth factors and cytokines and several membrane proteins [27]. The most 
important anti-apoptotic response is through Phosphoinositide 3 Kinase (PI3K) and Protein 
Kinase B (Akt) or the MAP (Mitogen-Associated Protein)-family of kinases, these proteins can 
directly inhibit caspases and thus prevent apoptosis [27]. Akt can also inactivate the apoptotic 
Bad protein and activate Nuclear Factor-kappa B (NF-kB) [28]. Transcription factor NF-kB, reverts 
Bax and Bad effects on mitochondria through the expression of proteins from the Bcl family, 
namely B-cell lymphoma 2 (Bcl-2) [25] (Figure 1-6). 
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Different BA, different apoptotic behaviour 
Hydrophobic BAs, such as DCA and LCA, activate cell death receptors in a ligand independent 
manner [29]; promote p53, EF2-1 and Cyclin D1 expression [23]; induce oxidative damage [30], 
promote Bax translocation to mitochondria [31] and mitochondrial dysfunction [24,30] (Figure 
1-6). All these modifications are sufficient for Caspase-6 activation which leads to a signalling 
cascade, leading to further caspase activation and apoptosis induction [20,23] (Figure 1-6). 
On the other hand, hydrophilic BAs prevent reactive oxygen species formation [24], Bax 
translocation to mitochondrial membrane [25], mitochondrial dysfunction [30] and death-
receptor induced apoptosis [32], ultimately inhibiting apoptosis (Figure 1-7). Furthermore, 
hydrophilic BAs activate pro-survival proteins such as PI3K, Akt and MAP Kinase Kinase Kinase 
(MAPKKK) [33]. It has also been shown that UDCA translocates the nucleus of hepatocytes via 
nuclear steroid receptors [34], such as glucocorticoids receptors, and affects gene expression 
and enhances p53 degradation [35] (Figure 1-7). Furthermore, both pro-apoptotic proteins 
Cyclin D1 and EF2-1 have their expression levels decreased by UDCA or TUDCA incubation 
[35,36], even in the presence of pro-apoptotic DCA [23]. Also, TUDCA has been linked with 
relieving endoplasmic reticulum stress, another apoptosis-inducing signal, functioning as a 
Figure 1-6 - Schematic representation of apoptosis induction through the extrinsic pathway, via 
death-receptor, or through the intrinsic pathway. Death-receptors activate caspases which are 
also activated by loss in mitochondrial integrity. The end result of both pathways is the 
formation of the apoptosome and apoptosis. Mechanisms for apoptosis prevention are also 
shown, from NF-kB-induced Bcl-2 expression to mitochondrial protection. Adapted from [22] 
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chaperone, inhibiting Caspase 12 activation [37]. 
Interestingly, the epithelial cells of the bile ducts and gallbladder, cholangiocytes, are in 
contact with high concentrations of BAs at all times [5]. These cells have developed evolutionary 
survival procedures to prevent BA apoptotic damage (Figure 1-6). In normal conditions, 
cholangiocytes express pro-survival proteins, for instance Bcl-2 and PI3K, as well as trigger 
mechanisms to inhibit apoptosis such as NF-κB activation and p53 cytoplasmic sequestration [5]. 
In summary, hydrophobic BAs promote apoptosis while hydrophilic BAs prevent apoptosis 
induced by hydrophobic BAs along with other apoptosis-inducing agents. 
 
Apoptosis and lipid rafts 
Lipid rafts are compartmentalisations within the plasma membrane driven by immiscibility 
between membrane components [21,38]. They are more rigid than the rest of the membrane as 
a consequence of a higher Chol and sphingolipids concentration [38]. These domains are called 
rafts since they were imagined as rigid domains floating in a fluid sea-like membrane [38]. In 
fact, lipid rafts are heterogeneous and highly dynamic structures, varying in lipid and protein 
composition [38]. They provide signalling platforms in vivo, capable of activating several cellular 
Figure 1-7 - Schematic representation of apoptotic prevention by hydrophilic bile acids UDCA and TUDCA. 
UDCA prevents cytochrome c release and Bax translocation to mitochondrial membrane. UDCA, also 
inhibits Cyclin D1, E2F-1 and p53 while promoting p53 degradation. TUDCA relieves ER stress, also 
inhibiting Caspase 12. Adapted from [20] 
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processes, specifically apoptosis [21]. 
For example, for the extrinsic pathway of apoptosis to have impact, the death-receptor Fas 
must be oligomerized and distributed to lipid rafts [39]. Recent studies have shown that 
ceramide, a degradation product of sphingomyelin and lipid raft component, has the ability to 
increase Fas oligomerization and activate apoptosis in a Fas-ligand-independent fashion [40]. 
Likewise, a recent anti-tumour drug, edelfosine, has been related with Fas translation to lipid 
rafts and consequent apoptosis induction [41,42]. Other pro-apoptotic membrane receptors, 
CD20 and CD5, can be activated without their specific ligand, as consequence of oligomerization 
by raft formation/fusion [43,44]. However, several Chol-depletion studies have shown a direct 
link between Chol deprivation, i.e. raft collapse, and apoptosis [19,45].  
 
1.4. Bile acid interaction with lipid membranes 
 
BAs are known to interact and partition to lipid membranes [46–51]. This interaction is 
stronger has the membrane Chol levels decrease [46]. Still, hydrophobic BAs are less affected by 
Chol membrane concentration than hydrophilic BAs [46]. It was also proposed that any BA could 
displace another BA from model membranes and that this effect was enhanced by Chol [46]. 
BAs have long been implicated in the dissolution of gallstones (Chol-rich depositions in the 
gallbladder). Patients with these depositions often take oral supplements of UDCA, however this 
particular BA has been shown to be a poor Chol solubiliser, whereas hydrophobic BAs, namely 
DCA, interact more efficiently with Chol [52]. 
Güldütuna and colleagues have proposed that UDCA mimicked Chol, increasing membrane 
order and rigidity as well as decreasing partition of other BAs to model membrane systems [47]. 
This study even claimed that UDCA position in membranes systems is identical to Chol, 
intercalated between other lipids [47] (Figure 1-8). Chol and UDCA would compete for the same 
position in the membrane. In this way, the effect of Chol in BA partition would be a consequence 
of BA displacement from the membrane. Permeabilization studies showed that hydrophobic BAs 
increase the membrane permeability and that UDCA could prevent this effect [47]. Hydrophobic 
BA-induced membrane permeabilization was also shown to happen in mitochondrial membrane, 
which was again prevented by UDCA [48]. 
Further studies involving BA position in membrane have asserted that taurine-conjugated 
hydrophilic BA are probably placed adhering to the membrane surface whereas taurine-
conjugated hydrophobic BA could be inserted into the membrane interior [50]. 
Remarkably, BAs were shown to partition greatly to sphingolipid-rich membranes [51] and 
alter their packing [49]. Also, BAs were shown to partition to membrane and alter membrane 
properties, such as fluidity, and permeability to small ions and proteins, and that hydrophilic BAs 
protect membranes from the effects of hydrophobic BAs [47,48,53]. 
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However, there is still a variety of questions concerning BA interaction with membranes: do 
all hydrophobic BAs intercalate phospholipids? Is hydrophilic BA interaction only superficial? Do 
they interact as monomers or as oligomers? 
 
1.5. Bile acid as putative modulators of membrane properties and cell 
signalling 
 
The plasma and mithocondrial membranes are, arguably, the most important organelle of 
the cell: membranes control a variety of signalling cascades, are docking sites for several 
enzymes, maintain concentration and hydroelectric gradients, etc. They are the entrance and 
exit points of the cell. Membranes are now seen as complex structures, composed of 
microdomains, e.g. lipid rafts, with different protein and lipid composition. Membrane domain 
composition might influence cell signalling and fate, e.g. aggregation of lipid rafts has been 
shown to concentrate apoptotic molecules increasing death receptor-ligand interaction 
[39,43,45]. 
From previous results concerning hydrophilic-hydrophobic BA interaction [46–48] two 
hypotheses were proposed: either BAs interact in solution, possibly aggregating, and this 
prevents partition to membranes; or partitioned-BAs alter membrane properties that prevent 
further BAs partition. Several studies have been published supporting the second hypothesis, 
suggesting a membrane-altering-effect for BAs [47–49]. The main argument is that this 
membrane-displacement effect is dependent on membrane composition and is maintained 
when vesicles are separated from buffer containing first BAs. 
Given the effect of BAs on death receptor activation in the plasma membrane [29], it is 
possible that BA-induced apoptosis is achieved through alterations of the plasma membrane 
structure. In fact, the apoptotic effects of hydrophobic BAs are suppressed upon Chol depletion 
and DCA has been shown to induce a significant change in both concentration and distribution of 
Chol in the plasma membrane [54,55]. On the other hand, a hydrophilic BA did not exhibit this 
effect suggesting that BAs may have different effects on lipid membranes depending on their 
molecular properties [54]. 
  
Figure 1-8 – Model for BA aggregation according to Guldutuna [47]. 
BA dimer would intercalate the phospholipids in the membranes, only 
leaving its carboxyl tail on the membrane/water interface 
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Objective 
The hypothesis of this work is that BAs act by changing membrane biophysical properties. 
The main objective is to determine the mechanism by which hydrophobic induces apoptosis and 
clarify the cytoprotective role of hydrophilic BAs. 
Three putative mechanisms for the cytoprotective role of hydrophilic BAs will be studied 
here: (1) hydrophilic BAs interact with hydrophobic BAs chemically, forming an innocuous, 
membrane-unaffecting, non-apoptotic species, (2) hydrophilic BAs can decrease hydrophobic 
BAs partition to lipid membranes, (3) hydrophilic BAs can counter the membrane altering effect 
of hydrophobic BAs. Any of these mechanisms would result in a prevention of membrane 
compromise, leading to cell survival. 
 
The work will be divided into four parts, each concerning with different approaches. First, 
labelled BA behaviour in aqueous solution will be assessed. Then labelled BA partition to model 
membrane system will be quantified. Unlabelled BA effect on membrane biophysical parameters 
will be observed. Lastly, unlabelled BA influence on live cells will be monitored. 
 
 
  
 
 
 
 
 
 
2. Materials and methods 
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Figure 2-1- Chemical structures of deoxycholic acid (DCA - top), ursodeoxycholic 
acid (UDCA - middle) and tauroursodeoxycholic acid (TUDCA - bottom). Notice 
how the only difference between DCA and UDCA is the position of the –OH 
groups: DCA is hydroxylated in carbons 3 and 12 whereas UDCA and TUDCA are 
hydroxylated in carbons 3 and 7. TUDCA is the taurine-conjugated version of 
UDCA. 
Deoxycholic acid (DCA) 
Ursodeoxycholic acid (UDCA) 
Tauroursodeoxycholic acid (TUDCA) 
2.1.Chemicals 
 
2.1.1. Reagents 
 
To better study the effect of hydrophobic and hydrophilic BAs on cells, DCA, UDCA and 
TUDCA were chosen because of more frequent use in biological studies (Figure 2-1). Also, 
fluorescent derivates of DCA and UDCA with nitro-2-1,3-benzoxa.diazol-4yl  (NBD) fluorophore 
were prepared by the Medical Research Group from the iMed, a research unit from Faculdade 
de Farmácia, Universidade de Lisboa (FFUL) (Figure 2-2). 
1-palmitoyl-2-oleoyl-sn-glicero-3-phosphocholine (POPC), N-palmitoyl-D-erythro-
sphingosylphosphorylcholine (PSM) and 1,2-dipalmitoyl-sn-glycero-3-phosphoethanolamine-N-
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biotinyl (DPPE-biotin) were purchased from Avanti Polar Lipids (Alabaster, AL, USA) and 
cholesterol (Chol) from Sigma-Aldrich (St. Louis MO, USA), All lipids were kept in Uvasol grade 
chloroform (Sigma-Aldrich) 
Unlabelled bile acids deoxycholic acid and tauroursodeoxycholic acid were purchased in 
sodium salt form from Sigma-Aldrich. Ursodeoxycholic acid sodium salt was purchased from 
Santa Cruz Biotechnologies (Santa Cruz, CA). 
HEPES, Sodium chloride (NaCl), avidin and poly-L-lysine were purchased from Sigma-
Aldrich. Perchloric acid and ammonium heptamolybdate were purchased from Merck 
(Darmstadt, Germany), ascorbic acid from VWR (Radnor, PA) and sucrose from Fluka (Buchs, 
Switzerland). 
  
NBD-derivatized DCA (DCA-NBD) 
Nitrobenzoxadiazole (NBD) 
NBD-derivatized UDCA (UDCA-NBD) 
Figure 2-2 - Chemical structures of NBD-derivatized deoxycholic acid (DCA-NBD - top), 
NBD-derivatized ursodeoxycholic acid (UDCA-NBD - middle), nitrobenzoxadiazole (NBD - 
bottom). Note that labeled BA lose the carboxyl groups and its negative charge and yield a 
longer side chain with a zwitterionic group attached. 
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2.1.2. Probes 
Nile Red, 1,6-Diphenyl-1,3,5-Hexatriene (DPH), 1-(4-Trimethylammoniumphenyl)-6-
Phenyl-1,3,5-Hexatriene p-Toluenesulfonate (TMA-DPH) and 1-[2-Hydroxy-3-(N,N-di-methyl-N-
hydroxyethyl)ammoniopropyl]-4-[β-[2-(di-n-butylamino)-6-napthyl] vinyl]pyridinium dibromide 
(ANEPPDHQ) were purchased from Invitrogen (Carlsbad, CA, USA). 1,2-dioleoyl-sn-glycero-3-
phosphoethanolamine-N-(lissamine rhodamine B sulfonyl) (Rho-DOPE) and 1,2-dipalmitoyl-sn-
glycero-3phosphoethanolamine-N-(7-nitro-2-1,3-benzoxa.diazol-4yl) (NBD-DPPE) were obtained 
from Avanti Polar Lipids. 
The following probes were used in this project. Probe concentrations were determined 
spectrophotometrically, from absorbance data and published absorption coefficients (Table 2-1). 
Probes were kept in UVasol-grade solvents at -26ºC.  
Table 2-1 – Summary of probe characteristics. Excitation/absorbance (exc/abs) and emission (em) maximum 
wavelengths are shown. Extinction coefficients and solvent used for concentration determination and storage are 
shown. 
Probe 
            (M
-
1.cm-1) 
Ref     
       
 
(nm) 
    
   
(nm) 
Solvent 
DCA-NBD        [56] 458 525-535 Methanol 
UDCA-NBD        [56] 458 525-535 Methanol 
Nile Red        [57] 552 636 Methanol 
DPH          [58] 355 420 Chloroform 
TMA-DPH        [58] 355 420 Chloroform 
ANEPPDHQ        [57] 460 Sil0 Chloroform 
Rho-DOPE        [56] 559 585 Chloroform 
NBD-DPPE        [56] 458 525-535 Chloroform 
 
2.1.3. Cell culture 
 
Human embryonic kidney 293 cells (HEK293) were used. These were grown in flasks and 
maintained in Dulbecco’s Modified Eagle Medium (DMEM) (Gibco, Carlsbad, CA) with 10% fetal 
calf serum and 1% penicillin-streptomycin at 37ºC in a humidified atmosphere with 5% CO2. 
 
2.2. Model membrane system preparation 
 
2.2.1. Large Unilamellar vesicles (LUVs) 
 
Required volumes of lipid and fluorescent probe stock solutions were mixed in 
chloroform and dried under a flow of dry nitrogen gas (N2). Last traces of solvent were removed 
overnight under vacuum. Multilamellar vesicles were then obtained through solubilisation in 
HEPES buffer (10 mM HEPES, 150 mM NaCl at pH 7.4, prepared in MillQ water) followed by 6 
freeze-thaw cycles. Thawing temperature used was always above the melting temperature of 
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the lipid with the highest melting temperature in the mixture. LUVs were produced by extrusion 
through a polycarbonate filters with 100 nm orifices (Whatman, USA) on a mini-extruder 
(Avanti). The lipid mixture was extruded at least 31 times. LUVs were kept at room temperature 
and in the dark until being used, at most for 48 hours after being prepared. 
 
2.2.2. Giant Unilamellar vesicles (GUVs) 
 
Required volumes of lipid and fluorescent probe stock solutions were mixed in 
chloroform to a final lipid concentration of 1 mM. This mixture was supplemented with 1 nM of 
biotinylated lipid DPPE-biotin. 2 µL of this solution were spread over each of the 4 faces of a pair 
of Platinum electrodes, which were dried in vacuum for about 15-30 minutes. Electrodes were 
the placed in 1 mL of a pre-heated 200 mM sucrose solution, in MilliQ water, and connected to 
signal generator for 1h15min. Electroformation occurred at a temperature over the melting 
temperature of the lipid with the highest melting temperature in the lipid mixture [59]. 
After electroformation, electrodes were shaken to release GUVs from electrodes and 
150 µL of GUV solution were transferred to an eight-well μ-Slide from Ibidi (Munich, Germany). 
A fraction of pipette tip had to be cut, enlarging tip diameter, in order to prevent GUV collapse 
during pipetting. μ-Slide had been previously incubated overnight with 0,1 mg/mL avidin and 
had been extensively washed with MilliQ water to remove excess avidin. Avidin binds to biotin 
from biotinylated lipids guaranteeing GUV immobilization in the bottom of the slide. Each well 
was filled with 250 µL of buffer. Buffer osmolarity was adjusted using an A0300 Osmometer 
from Knauer (Berlin, Germany) to match the osmolarity of the 200 mM Sucrose solution (±5%) 
so as to prevent GUVs from bursting due to osmotic pressure. GUVs were left to equilibrate in 
the slides for 30min before measurements. 
 
2.2.3. Lipid quantification 
 
Phospholipid concentration, namely POPC, PSM and biotinylated lipid concentration, was 
assessed using a methodology described elsewhere [60]. Briefly, this method is based on the 
determination of inorganic phosphate obtained after acid hydrolysis, using perchloric acid, from 
phospholipids at 200ºC. Released phosphate reacted with ammonium heptamolibdate yielding 
phosphomolybdic acid, which is reduced by ascorbic acid to a blue compound, 
spectrophotometrically detectable at 815nm. 
Chol concentration in stock solution was determined gravimetrically with a high-precision 
scale. Empty vials were weighted in and then filled with a certain volume of Chol stock solution. 
Chloroform, was evaporated using nitrogen gas and kept in vacuum overnight to ensure 
complete solvent evaporation. Vials with Chol film were weighted and Chol mass was 
determined by the difference in masses from registered weights. 
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2.3. Cell membrane labelling and BA incubation 
 
Cells were seeded in eight-well μ-Slides from Idibi at 20 000 cells per well to achieve 
approximately 80% confluence. Slides were precoated with poly-L-lysine. 
Di-4-ANEPPDHQ was used for plasma membrane labelling to a final concentration of 10 μM 
in Phosphate Buffered Saline solution (Gibco). Cells were incubated for 30min with probe 
solution and then washed with DMEM. Cells were then incubated for another 30min with either 
100 μM of DCA or TUDCA or TUDCA followed by DCA in DMEM. Cells were not washed after this 
treatment. 
DCA-NBD and UDCA-NBD were added to a final concentration of 20 μM to unlabelled cells 
and incubated for 30min before imaging. 
 
2.4. Absorption and fluorescence measurements 
 
2.4.1. UV-Vis absorption spectroscopy 
 
UV-Vis absorption spectra were performed in a Shimadzu UVPC-3100 
spectrophotometer (Shimadzu, Kyoto, Japan). For probe concentration determination, 
1cm 0.4cm Hellma quartz cuvettes were used and absorption coefficients considered for each 
probe are shown in Table 2-1. For phospholipid concentration determination 1 cm 1 cm Hellma 
quartz cuvettes were used. 
2.4.2. Steady-state fluorescence spectroscopy 
 
Fluorescence steady-state measurements were performed in a SLM-Aminco 8110 Series 
2 spectrofluorimeter (Rochster, NY) with double excitation and emission monochromators (MC-
400, Rochster, NY), in right-angle geometry. Light source was a 450-watt Xe arc lamp and the 
reference was a Rhodamine B quantum counter solution. Temperature was controlled by a 
thermostated cuvette holder and magnetic stirring was used. 
Typically, measurements were made with 4 and 16 nm bandwidth, for excitation and 
emission respectively. Polarization of excitation and emission light was achieved using Glan-
Thompson polarizers. Excitation and emission polarizers were positioned at 0º and 54.7º angles 
respectively. Both 1 cm 1 cm and 0.5 cm 0.5 cm Hellma quartz cuvettes were used in this 
study. Fluorescence intensities are calculated through integration of the obtained spectrum. 
When using high fluorophore concentrations inner-filter effects must be considered. 
Fluorescence intensity is proportional to the intensity of the exciting light, when using mixture 
with high absorbance at the exciting wavelength, the intensity of the exciting light will vary in 
the optic path [61]. This will lead to an apparent decrease in fluorescence which can be 
corrected using the following formula [62]: 
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 Eq. 1 
   
Fluorophore absorbance is calculated using fluorophore concentration and the 
extinction coefficient present in Table 2-1. This correction is only valid if             , which 
was always observed. 
Background fluorescence intensity was subtracted using a solution containing either 
unlabelled vesicles and/or unlabelled bile acids. Excitation and emission spectra were corrected 
for different instrumental response, due to inherent lamp and monochromator characteristics, 
as well as wavelength-dependent photomultiplier sensitivity. 
Fluorescence anisotropy measurements are based on the quantification of the 
depolarization of fluorescence after excitation of fluorophores with polarized light. In this way, 
fluorescence anisotropy is very sensitive to the rotational dynamic of the fluorophore. Steady-
state anisotropies were determined according to the following equation (Eq. 2, [61]): 
     
         
           
 Eq. 2 
   
where the different intensities,    , are the steady-state vertical and horizontal 
components of the fluorescence emission with vertical excitation,     and     respectively, and 
horizontal excitation,     and     respectively, to the emission axis. The latter pair of 
components is used to calculate the G factor (         ), which is a correction for the 
different sensitivity of the optics in the spectrofluorimeter to polarized light.  
Fluorescence anisotropy is highly dependent on the lifetime of the fluorophore. The 
main driving force behind depolarization is its rotational diffusion. Consequently, if the 
fluorophore has free motion and remains on the excited state for a large amount of time, its 
fluorescence anisotropy will be close to zero. Now, if the lifetime is decreased, fluorescence 
anisotropy will be higher since the fluorophore will not have as much time to rotate. The 
relationship between fluorescence lifetime and anisotropy is described by the Perrin equation 
(Eq. 3, [61]): 
     
  
      ⁄
 Eq. 3 
   
where    is the fundamental anisotropy of the fluorophore,    is the average lifetime 
the fluorophore spends in the excited state and   is the rotational diffusion coefficient. 
 
2.4.3. Transient-state fluorescence spectroscopy 
 
Fluorescence decays were obtained with the Time-Correlated Single-Photon Timing 
technique (TCSPT). A laser pulse excites the sample and starts a voltage ramp, which is stopped 
when a sample-emitted photon is detected. The measured voltage is proportional to the time 
between sample excitation and photon detection. The excitation laser is fired at a high 
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repetition rate and experimental conditions are adjusted so that, for each excitation pulse, there 
is less than 1% probability of detecting a photon. Sequentially, a multichannel analyser converts 
the voltage to a temporal channel, using an analogue-digital converter. Through the 
accumulation of several pulses it is possible to acquire a histogram of photon counts as a 
function of elapsed time since sample excitation. 
The fluorescence intensity decays were obtained with excitation and emission polarizers 
at 0º and 54,7º respectively. Anisotropy decays were obtained alternating emission polarizer 
position between 0º (vertical) and 90º (horizontal) degrees, keeping the excitation polarizer in 
the vertical position. Light was completely depolarized after passing through the polarizers. In 
this way no correction factor was needed, and detected light was proportional to emitted light. 
Fluorescence anisotropy is calculated using a simplified version of the previous equation (Eq. 4, 
[61]): 
        
             
               
 Eq. 4 
   
Excitation pulses were produced by a Ti-Sapphire solid state laser system (used for 460 
nm excitation) or a frequency-doubled cavity-dumped dye laser of DCM (Coherent 701-2) (used 
for 340 nm excitation). Emission wavelengths were selected using a Jobin Yvon HR320 
monochromator (Horiba Jobin Ivon Inc.). The excitation pulse profile was obtained using a 
scattering Ludox mixture, an aqueous solution of colloidal silica (Sigma-Aldrich). Decay curves 
were stored in 1024 channels and the used time-scale varied according to experimental 
conditions, from 9.76 to 48.8 ps/ch. The number of counts in the peak channels of the sample 
decay and instrumental response function were 20 000 to 50 000 respectively. 0.5 cm 0.5 cm 
Hellma quartz cuvettes were used and samples were always under magnetic stirring. All 
measurements were performed at room temperature. 
 
2.4.3.1. Fluorescence decay analysis 
 
Consider the fluorescence intensity of a sample through time, at      , immediately 
after the excitation pulse, the fluorescence intensity is maximum and decreases through time at 
an exponential rate. For monoexponential decays, this process can be described by the following 
equation (Eq. 5, [61]): 
            
  
 ⁄   Eq. 5 
   
where    is the fluorescence intensity immediately after excitation and   is the average 
time the fluorophore remains on the excited state. 
For more complex decays, a sum of exponentials has to be used to describe the decay. 
Consequently, the intensity decay of a fluorophore is given by (Eq. 6, [61]): 
      ∑      
  
  ⁄  
 
   
 Eq. 6 
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where    and   , are the pre-exponential factors and lifetime of the  th component. 
The association between steady-state fluorescence intensity and its decay,     , is given 
by (Eq. 7, [61]): 
 
  ∫       
 
 
 
Eq. 7 
   
Solving Eq. 7 with the general decay equation (Eq. 6) we reach a parameter,  ̅, which is 
called lifetime-weighted quantum yield (Eq. 8, [61]). 
 
  ∑    
 
   
  ̅ 
Eq. 8 
   
The lifetime-weighted quantum yield of a fluorophore is proportional to fluorophore 
quantum yield. 
The average lifetime of a fluorophore exhibiting a multi-exponential decay is calculated 
by the following equation (Eq. 9, [61]): 
     
∫         
 
 
∫       
 
 
 
∑     
  
 
∑     
 
 
 
∑     
  
 
 ̅
 Eq. 9 
   
To analyse the decays obtained by TCSPT one must consider that they do not directly 
represent the fluorescence emission kinetics of a sample excited with an infinitesimal-timed 
pulse. The excitation pulse lasts for several picoseconds and the experimental curves,        , 
are distorted by the finitesimal duration of the pulse. In this way, the decay law is convoluted 
with the pulse function and         by the following equation (Eq. 10, [61]): 
         ∫    
                
 
     
 Eq. 10 
   
Decay curves were analysed with TRFA (version 1.4) from Scientific Software 
Technologies Centre (Belarusian State University). Briefly, this programs fits the previous 
equation (Eq. 10) to the experimentally obtained decay,        , using the empirically obtained 
instrumental response curve,     , and recovers the decay law,      from optimizing    and    
values. A non-linear regression by the least-squared method based on Marquardt algorithm [63] 
was employed. Fits were accepted when    value was lower than 1.4 and weighted residuals 
and autocorrelation plots were randomly distributed around 0. 
 
Fluorescence anisotropy decays 
Time-resolved fluorescence anisotropy is calculated by Eq. 4. The fluorescence 
anisotropy decay can be described by a sum of exponentials, described in the following equation 
(Eq. 11, [61]): 
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      ∑       
 
  
⁄  
 
   
    Eq. 11 
   
Where    and    represent the initial anisotropy and rotational diffusion coefficient of 
the  th component of the decay. The    parameter represents the limiting anisotropy of a 
sample, which can be a sign of restricted depolarization. The utility of this parameter will be 
discussed further below. Note that  ∑   
 
          . 
Obtained decays were also analysed in TRFA but in a more complex manner. Firstly, the 
signal from both components was adjusted to a global intensity decay,        , by solving the 
following system of equations for         (Eq. 12, [61]): 
 
{
 
    
       
       
 
[           ]
   
       
       
 
[         ]
 Eq. 12 
   
First,    and    values were recovered from fitted         curves as described above. 
Then a                 curve was fitted to the         curve optimizing   ,    and    and    values 
while maintaining fixed the    values recovered from the first fit. Once again, a nonlinear 
regression by the least-squares method based on the Marquardt algorithm was employed [63]. 
The criteria for accepting fits were the same as for non-polarized fluorescent decays. 
 
2.4.4. Partition coefficient determination 
 
To determine partition coefficients to vesicles as a function of lipid concentration [64] 
the following equation was fitted to the partition data (Eq. 13): 
   
            
         
 Eq. 13 
   
where    and    is probe fluorescence intensity in solution or in the lipid membrane, 
respectively;    is the partition coefficient and    is lipid molar volume, which is assumed to be 
0.75 dm3mol-1.    is assumed to be the intensity obtained in the absence of lipid.    and    were 
optimized using the least-square method with Origin8 (OriginLab, Northampton, MA, USA). 
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2.4.5. FRET studies 
 
Theory 
Förster resonance energy transfer (FRET) occurs when an excited fluorophore (termed 
donor) transfers energy to a fluorophore in the ground-state (termed acceptor) in a non-
radiative, long range dipole-dipole coupling mechanism. For FRET to occur, three conditions 
ought to be verified: donor emission spectrum must overlap with acceptor excitation spectrum; 
donor and acceptor molecules must be in proximity (typically <100 Å apart); donor emission and 
acceptor excitation momenta must not be perpendicular to each other. 
FRET efficiency,  , ranges from 0 to 1 and is the standard parameter for comparing FRET 
experiments. In case of FRET to a single acceptor, it is dependent on the sixth power of the 
quotient between the distance,  , between the two fluorophores and the Förster radius (  ) of 
the donor-acceptor pair, the distance upon which       (Eq. 14, [61]). 
 
  
 
  (
 
  
)
  Eq. 14 
   
The Förster radius is calculated for each donor/acceptor pair through the following 
equation (Eq. 15, [61]): 
   
                    
            
   Eq. 15 
   
where   is the refraction index,    is the donor quantum yield in the absence of the 
acceptor,   is the orientational factor, dictated by the relative orientation of donor emission and 
acceptor excitation momenta.   is the overlap integral between donor emission and acceptor 
excitation spectra and is described by the following equation (Eq. 16, [61]): 
   ∫            
   
 
 
           Eq. 16 
   
Several artefacts must be taken into account when designing and interpreting FRET 
results, as FRET efficiencies are strongly dependent on   , that is influenced by several 
parameters. 
 
Obtaining FRET efficiencies 
Energy transfer is a dark process that cannot be measured directly, one can only 
measure the end result, either acceptor sensitized-fluorescence or loss of donor fluorescence. 
Several complications are involved in FRET efficiencies calculation through acceptor emission, 
e.g., results need to be corrected, namely direct acceptor excitation and fluorescence upon 
donor excitation, and the differences in extinction coefficients between donors and acceptors 
must be accounted for. On the other hand, loss of donor fluorescence is a fairly simple and 
immediate way of calculating FRET efficiencies. Donor quantum yield decreases in the presence 
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of the acceptor and this can be quantified either by changes in steady-state fluorescence 
intensity,  , or donor lifetime,   (Eq. 17, [61]): 
     
   
  
   
   
  
   
   
  
 Eq. 17 
   
where the   and    indexes represent donor alone or in the presence of the acceptor, 
respectively. In the FRET experiments present in this study, FRET efficiencies were calculated 
using the decrease in fluorescence lifetime and intensity of the donor molecule, NBD-DPPE, in 
the presence of the acceptor, Rhodamine-DOPE. NBD lifetime decay was acquired from photons 
with 500-530 nm in order to avoid contamination from acceptor fluorescence.    for the NBD-
DPPE/Rho-DOPE FRET pair was determined by Eq. 15 and Eq. 16 to be approximately 50 Å. 
 
Estimating FRET efficiencies 
It is possible to calculate an expected FRET efficiency value, assuming a random 
distribution of donor and acceptor molecules. Since membrane thickness is smaller than    (40 
to 50 Å, respectively), energy transfer can occur between both donors and acceptors in the same 
membrane leaflet (in-plane) or donors and acceptors in opposing leaflets (out-of-plane). 
The donor decay law of the donor in the presence of the acceptor becomes (Eq. 18, Eq. 
19 and Eq. 20, [56]): 
                    Eq. 18 
   
                    
  ∫
               
  
 
 
    Eq. 19 
   
      
      √  
  Eq. 20 
   
where    is the acceptor density in each bilayer leaflet, and   is the distance between 
the plane of donor and acceptors. In the calculation of the surface density of acceptors, an area 
per molecule of 66.4, 47.8 and 37.7    for POPC, PSM and Chol, respectively, were considered. 
 
2.5. Confocal fluorescence microscopy 
 
All measurements were performed on a Leica TCS SP5 (Leica Microsystems CMS GmbH, 
Manheim, Germany) inverted confocal microscope (DMI6000). Excitation lines provided by an 
argon laser were focused into the sample by an apochromatic water immersion objective (63x, 
NA 1.2; Zeiss, Jena Germany). A 111.4 μm diameter pinhole in front of the image plane blocked 
out-of-focus signals. 
Essentially, only two fluorophores were visualized by confocal microscopy: NBD, in DCA-
NBD, UDCA-NBD or DPPE-NBD, and Rhodamine, in Rho-DOPE. The NBD group was excited at 458 
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nm and emission was collected between 480-570 nm. Rhodamine was excited at 514 nm and 
emission was collected between 570-620 nm. 
 
GUV and cell images 
XY slices separated by 0.4 μm along the z-axis were obtained at 200 or 400 Hz. 2d 
maximum intensity projections were constructed using the maximum intensity projection 
method [65]. Every slice was acquired in two different channels using the excitation and 
emission described above. Images were treated with ImageJ software (Wayne Rasband NIH, 
USA). 
For ld percentage determination, two maximum intensity projections of a GUV were 
obtained, the top and bottom hemispheres. The ld percentage was the ration between the 
Rhodamine area in the two hemispheres and the total GUV area (Eq. 21): 
     
                       
                       
 Eq. 21 
   
where     is the fraction of ld in the GUV and                the area of i in a given 
hemisphere determined with ImageJ software. 
 
2.5.1. Fluorescence lifetime imaging microscopy 
 
The microscope was coupled with a Ti-Sa multiphoton laser that allowed Fluorescence 
Lifetime Imaging Microscopy (FLIM). This technique is the imaging counterpart to the transient 
state fluorescence spectroscopy. Using the TCSPT methodology, samples were excited at 840nm 
using two-photon excitation that efficiently excited di-4-ANEPPDHQ. Full frame TCSPT 
histograms were recorded for 60s, with an open pinhole and fluorescence emission was selected 
using a 535/85 band-pass filter. The instrumental response curve was obtained through the 
measurement of the second-harmonic generation from urea crystals, using the same excitation 
wavelength. FLIM data analysis was performed with SPCImage software (Becker & Hickl) and the 
methodology was identical to the one employed for macroscopic time-resolved fluorescence 
decay analysis. 
 
2.6. Isothermal titration calorimetry (ITC) 
 
Titration was performed on a VP-ITC instrument from MicroCal (Northampton, MA) at 25ºC, 
injection speed of 0.5 μL/s, stirring speed 459 rpm and reference power 10 μcal/s. The first 
injection of 2 μL was disregarded to account for diffusion from/into the syringe tip during the 
equilibration period, still, the injected amount was taken into account in the calculations. The 
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titration proceeded with additions of 5 μL of injectant per step. All solutions had been previously 
degased for 15min. 
The obtained thermogram was integrated using the data analysis software Origin 7.0 as 
modified by MicroCal to deal with ITC experiments. Concentrations in the cell were calculated, 
taking into account the volume that overflows the cell due to the addition of solution from the 
syringe considering that overflow is faster than mixing, meaning that the composition of the 
solution leaving the cell is the equilibrium composition before the addition. The predicted heat 
evolved in titration step   is calculated by Eq. 22: 
       (         
           
    (  
  
     
))       Eq. 22 
   
where    is the molar partition enthalpy,          
  is the number of moles of BA bound to 
the lipid after injection  ,    is the volume injected,       the volume of the cell and      the 
dilution heat [66]. 
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3.1. Bile Acid aggregation 
 
The first part of this thesis will focus on the aggregation of BAs in buffer. The first goal of this 
section is to establish if labelled BAs are good mimics of unlabelled BA. The second goal is to 
characterize the submicellar aggregation pattern of the labelled BAs and to test if it the 
aggregation pattern of DCA-NBD is affected by interaction with hydrophilic BAs at submicellar 
concentrations. 
Fluorescence emission and excitation spectra in aqueous solution were obtained for the 
two labelled BAs, DCA-NBD and UDCA-NBD. The labelled BAs present identical excitation and 
emission spectra in buffer (Figure 3-1). The excitation maximum is at 480nm and both labelled 
BAs present a local excitation maximum at 340nm, corresponding to a π→π* transition, typical 
of the NBD fluorophore [67]. Fluorescence emission spectra have a maximum at about 540nm. 
This value changes in accordance to the polarity of the NBD environment [67]. Additionally, the 
NBD fluorophore presents significantly lower quantum yields in aqueous solutions that when in 
more hydrophobic environments, such as liposomes or organic solvents [67]. 
  
Figure 3-1 – Fluorescence emission and excitation spectra from DCA-NBD (blue) and UDCA-
NBD (red) in HEPES buffer. For the excitation spectra (dashed), fluorescence emission was 
recovered at 540nm. For emission spectra (full), excitation was conducted at 460nm. Spectra 
were normalized to the maximum intensity. 
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3.1.1. Critical Micellar Concentration determination 
 
Critical micellar concentration (CMC) is the concentration at which micelles of solute 
start to form. To determine if labelled BAs are good mimics of their respective BA, the CMCs of 
DCA and UDCA were determined using both DCA-NBD or UDCA-NBD and the hydrophobic probe 
Nile Red. This hydrophobic probe exhibits preferential partition to apolar environments, such as 
micelles and will be used as a control to determine if the labelled BAs present readily partition to 
micelles of unlabelled BAs. 
To obtain micelles of BAs, volumes of each BA stock solution were stepwise added to a 
cuvette with 2 μM pf the respective labelled BA or Nile Red. Probe fluorescence emission spectra 
and fluorescence anisotropy were recorded as a function of total BA concentration. 
 
DCA micellization 
 For DCA micellization studies, DCA was added to a 2 μM DCA-NBD solution; from 5 μM 
up to ≈ 10 mM total BA. An increase in fluorescence intensity and anisotropy is observed when 
DCA concentration reaches the 3 mM (Figure 3-2A). Fluorescence intensity and anisotropy 
plateau at a DCA concentration of 7 mM. Note that, the fluorescence intensity and anisotropy 
variations occur at the same DCA concentrations. This increase in fluorescence intensity can be 
associated with micelle formation as micelles sequester the NBD group from the solvent into a 
more apolar surrounding. This is complemented by a shift in the emission spectra of DCA-NBD to 
lower wavelengths (Figure 3-2B). An increase in the anisotropy of DCA-NBD is also indicative of 
DCA-NBD incorporation in DCA micelles, since micelles have a slower rotational diffusion than 
free DCA-NBD, which leads to less fluorescence depolarization of the probe. 
From Figure 3-2A, three states of aggregation can be assigned to the results. Firstly, a 
premicellar state is assumed from 5 μM up to 2 mM, since there is no change in DCA-NBD signal. 
Above 2 mM of DCA, DCA-NBD quantum yield increases, which is indicator of DCA micelle 
formation, as discussed above. At concentrations over 6 mM, DCA-NBD signal is again constant, 
and it is assumed that all DCA-NBD is already incorporated in micelles. The CMC value for DCA 
can be calculated by the intersection between the tendency lines from the first and second 
state, premicellar and micelle formation [6]. Considering the fluorescence intensity signal (Figure 
3-2A), the CMC value obtained is 2.5 mM. For the anisotropy signal, the mathematical treatment 
is the same and the CMC values retrieved is almost identical, 2.3 mM. 
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DCA was also stepwise added to a 2 μM solution of Nile Red. With Nile Red, a more 
gradual increase in fluorescence intensity is observed (Figure 3-3). Due to a very low 
fluorescence intensity signal of Nile Red in the absence of micelles, fluorescence emission 
anisotropy cannot be used to detect the CMC value, as errors associated with the measurements 
were very high. Although the shape of the curve is similar, the quantum yield of Nile Red is less 
sensitive to DCA micelle formation, leading to a CMC value of 3.3 mM. Additionally, total 
incorporation of Nile Red to DCA micelles is not achieved at 10 mM. The higher sensitivity of 
DCA-NBD to DCA micelle formation is indicative of a higher buffer to DCA micelle partition 
coefficient (       ). In fact while Nile Red is still not fully incorporated in micelles at 10 mM 
Figure 3-2 - DCA-NBD fluorescence emission intensities, anisotropies (A) and normalized 
emission spectra (B) as a function of DCA concentration. DCA was stepwise added to 2 μM 
of probe solution, fluorescence emission spectra were recorded. (A) DCA-NBD fluorescence 
emission intensity (closed squares) and anisotropy (open circles) as a function of total DCA 
concentration. Full black line represents the trend of the premicellar fluorescence intensity 
signal and black dashed line represents the trend upon micelle formation. Intersection 
between the two black lines is at 2.5 mM as shown by the black dotted line. (B) DCA-NBD 
emission spectra at several DCA concentrations, as shown by  the tendency arrow. Spectra 
were normalized to value at maximum intensity. DCA-NBD was excited at 460 nm and 
emission was recovered between 480-700 nm, anisotropy was measured at 540nm. 
Fluorescence intensities were corrected for sample dilution. 
A 
B 
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DCA, DCA-NBD achieves this at 6-7 mM DCA. 
 
 
UDCA micellization 
For UDCA micellization studies, UDCA was added to a 2 μM UDCA-NBD solution; from 5 
μM up to ≈ 15 mM total BA. An increase in fluorescence intensity and anisotropy is observed for 
UDCA concentrations over 0.5 mM (Figure 3-4A). The increase in fluorescence intensity and 
anisotropy correlates with UDCA aggregate formation and is also accompanied by a blue-shift of 
the emission spectra (Figure 3-4B). 
Nevertheless, this behaviour is distinct from what was seen with DCA. In this case, 
UDCA-NBD is sensitive to much smaller concentrations of UDCA (≈0.5 mM). Up to this 
concentration the sample is likely in a monomeric state. Above this concentration, the quantum 
yield of UDCA-NBD progressively increases until a plateau is reached around 7 mM UDCA and 
increases again around 9 mM UDCA. 
Given that the reported values for the CMC of UDCA are within 7 to 10 mM [6,10,13], it 
is likely that the increase of UDCA-NBD quantum yield at low UDCA concentration corresponds 
to the interaction of the probe with premicellar aggregates (primary aggregates) of the BA. In 
this case, UDCA forms a type of aggregate which somehow shields UDCA-NBD from the solvent. 
A critical premicellar aggregate concentration value of 0.5 mM can be recovered from the profile 
(Figure 3-4A). 
Figure 3-3 - Nile Red (open squares) and DCA-NBD (closed squares) fluorescence 
intensity as a function of total DCA concentration. DCA was stepwise added to 2 
μM of probe solution, and fluorescence emission spectra were recorded. DCA-NBD 
was excited at 460 nm and emission was recovered between 480-700 nm; Nile Red 
was excited at 530nm and emission was recovered between 550-750 nm. 
Fluorescence intensities were corrected for samples dilution. 
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These aggregates increase in number and over 9 mM, large micelles are formed as 
typically reported in the literature. This final structure transition in aggregate properties, shields 
even more efficiently UDCA-NBD from the solvent. This transition is possibly associated with the 
formation of larger aggregates (secondary aggregates or micelles). These results fit the model 
for BA aggregation in a two-step fashion, proposed by Small [14]. 
The fluorescence intensity behaviour of Nile Red is similar to UDCA-NBD (Figure 3-5). 
However, the quantum yield of UDCA-NBD is also significantly more sensitive to BA 
Figure 3-4 - UDCA-NBD fluorescence emission intensities, anisotropies (A) 
and normalized emission spectra (B) as a function of UDCA concentration. 
UDCA was stepwise added to 2 μM of probe solution, fluorescence 
emission spectra were recorded. UDCA-NBD was excited at 460 nm and 
emission was recovered between 480-700 nm. Fluorescence anisotropy was 
measured at 540nm. Fluorescence intensities were corrected for sample 
dilution. (A) UDCA-NBD fluorescence emission intensity (closed squares) 
and anisotropy (open circles) as a function of total UDCA concentration. 
Full black line represents the trend of the monomer fluorescence intensity 
signal and black dashed line represents the trend upon premicellar 
aggregate formation. Intersection between the two black lines is at 0.5 mM 
as shown by black dotted line. (B) UDCA-NBD emission spectra at several 
UDCA concentrations, as shown by the tendency arrow. Spectra were 
normalized to the value at maximum intensity. 
A 
B 
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concentration than Nile Red. 
Interestingly, both probes were sensitive to the formation of premicellar or primary 
aggregates of UDCA, whereas these were undetected with DCA. Since DCA is in fact more 
hydrophobic than UDCA, it is highly unlikely that premicellar aggregates are not formed for this 
BA [6]. In this way, neither DCA-NBD nor Nile Red interact with DCA premicellar structures or 
these present significant structural differences to premicellar aggregates of UDCA. In fact, as 
observed from Figure 3-4B, formation of UDCA micelles is accompanied by a notable blue shift of 
UDCA-NBD fluorescence. This blue shift in the fluorescence emission spectra is more significant 
than the observed for DCA-NBD in DCA micelles (Figure 3-2B), confirming that the micelle 
aggregates are structurally different for these two BAs. In the case of DCA, after binding of DCA-
NBD to a putative premicellar DCA aggregate, the NBD fluorophore remains fully exposed to the 
polar solvent, and fluorescence characteristics are unchanged. 
 
TUDCA micellization 
TUDCA micelle formation was also studied with Nile Red, TUDCA was stepwise added to 
buffer containing 2 μM of Nile Red, from 5 μM to 15 mM and fluorescence emission was 
recorded. Nile Red fluorescence intensity was stable until 0.5 mM, and above this concentration 
it increased, reaching a plateau around 2 mM (Figure 3-6). Around 4 mM TUDCA, Nile Red 
quantum yield becomes highly sensitive to BA concentration and fluorescence intensity 
increased several fold. Much like UDCA; its unconjugated version, TUDCA apparently presents a 
two-phase behaviour with two CMCs recovered, 0.5 mM and 5 mM, corresponding to the onsets 
of premicellar and micellar aggregate formation. 
Figure 3-5 Nile Red (open squares) and UDCA-NBD (red squares) fluorescence 
intensity as a function of total UDCA concentration. UDCA was stepwise added to 2 
μM of probe solution, and fluorescence emission spectra were recorded. UDCA-
NBD was excited at 460 nm and emission was recovered between 480-700 nm; Nile 
Red was excited at 530nm and emission was recovered between 550-750 nm. 
Fluorescence intensities were corrected for samples dilution. 
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Literature comparison 
In Table 3-1, all CMCs determined above are shown, along with the values taken from 
the literature. CMC values varied significantly depending on the method used for micelle 
detection. The main difference between this study and others is that, for UDCA and TUDCA, a 
two-step aggregation pattern was observed. 
Table 3-1 - Critical micellar concentration values for DCA, UDCA and TUDCA. Values were recovered from labelled 
BA or Nile Red fluorescence intensity or anisotropy curves 
Bile Acid Probe 
CMC1 (mM) CMC2 (mM) CMC from 
Literature (mM) Ф <r> Ф <r> 
DCA 
DCA-NBD 2.5 2.3 
- - 
2.4-4.5 
[10–13,15] Nile Red 3.3 - 
UDCA 
UDCA-NBD 0.5 0.4 9.0 8.9 7-10 
[6,10,13] Nile Red 1.0 - 12.5 - 
TUDCA Nile Red 0.5 - 4.7 - 
2-7 
[6,9,10,13,14] 
 
The CMC value recovered for DCA is in the range from previously reported values. The 
1st CMC value for both TUDCA and UDCA is approximately the same which would suggest that 
the first step of aggregation is independent of the taurine aminoacid. The 2nd CMC value is 
coherent with the notion that conjugation reduces the CMC values. Both 2nd CMC values for 
Figure 3-6 – Nile Red fluorescence emission intensities as a function of 
TUDCA concentration. TUDCA was stepwise added to 2 μM of Nile Red 
solution, fluorescence emission spectra were recorded. Lines represent the 
trend of the premicellar fluorescence intensity signal (full black), 
premicellar aggregates formation (black dashed), premicellar fluorescence 
intensity signal (green dotted) and micelle formation (green dashed). 
Intersection between the two black lines is at 0.5 mM as shown by black 
dotted line. Intersection between the two green lines is at 5 mM as shown 
by the green dotted line. Nile Red was excited at 530nm and emission was 
recovered between 550-750 nm. Fluorescence intensities were corrected 
for sample dilution. 
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UDCA and TUDCA are in the range of reported values, which possibly indicates that previous 
studies are only detecting the second type of UDCA and TUDCA aggregate. 
The behaviour from UDCA and DCA is markedly different. For UDCA there is a gradual 
increase in fluorescence intensity and anisotropy from the first CMC and then after the second 
CMC only a short increase is perceived, whereas for DCA there is a slight increase in intensity 
and anisotropy after the only CMC. This might imply that the aggregation mechanisms are 
different for these two molecules.  
The goal of these studies was to assess whether labelled BA effectively interact with 
unlabelled BAs and determine the onsets of premicellar aggregation. However, as discussed in 
the case of DCA, premicellar aggregates of this BA are possibly undetectable with this 
methodology. Taking that into account, a new methodology was devised to tackle this issue. 
 
3.1.2. Critical Aggregation Concentration 
 
In order to determine if a submicellar aggregation constant could be recovered for DCA 
as well, labelled BAs were added stepwise to a buffer solution and fluorescence emission spectra 
and anisotropy were recorded as a function of labelled BA concentration. 
When DCA-NBD concentration is above 2 μM, a linear relationship between 
fluorescence intensity and concentration is no longer observed (Figure 3-7A). This also happens 
for UDCA-NBD, again over 2 μM (Figure 3-7C). The deviation from a linear behaviour means that 
there is formation of a species with an inferior quantum yield. This species can be aggregated 
DCA-NBD or UDCA-NBD. The anisotropy of neither DCA-NBD nor UDCA-NBD changes in the 
concentration range shown and is very small, almost zero (Figure 3-7, B and D). Anisotropy 
insensitivity to aggregate formation is because aggregates are dark or possess a very low 
quantum yield (they do not fluoresce and do not contribute to fluorescence anisotropy), or have 
an identical rotational diffusion coefficient as monomers. Additionally, in the case of 
aggregation, an increase in fluorescence emission anisotropy could be mitigated by fluorescence 
depolarization through energy migration (HomoFRET) [61]. 
The lifetime of labelled BAs decreases when concentration increases (Figure 3-8A). This 
rules out the formation of only fully dark aggregates (since lifetime-weighted quantum-yield 
would be insensitive to these species), and favours the formation of at least a fraction of 
aggregates with a lower-than-monomer quantum yield. Anisotropy decays do not change with a 
concentration increase (Figure 3-8B). 
To test if this aggregation is due to the presence of the NBD group, a 1:1 mixture 
containing both labelled BA and unlabelled BA was prepared and added stepwise to buffer 
solution. NBD emission spectra and anisotropy were measured as function of probe 
concentration. If aggregation is dependent on NBD group, the overall look of the curve should be 
similar to the one obtained with only labelled molecule. If aggregation is based on interaction 
between native parts of the molecules, the curve should have the same aspect but a loss of 
linearity should occur for higher concentrations of labelled BA. 
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For DCA, almost the same profile is obtained when using the 1:1 mixture (Figure 3-7A), 
which means that aggregation occurs mainly between DCA-NBD monomers. As previously seen, 
anisotropy of DCA-NBD was invariant in the concentration range studied. 
On the other hand, a great difference exists between the pure UDCA-NBD curve and the 
mixed UDCA-NBD curve (Figure 3-7B). With the 1:1 mixture aggregation again occurs at 2 μM; 
however, the intensity of the curve is higher. This means that UDCA-NBD is interacting with 
unlabelled UDCA and aggregation between UDCA-NBD molecules is disrupted. 
Clearly labelled BAs aggregate at submicellar concentration. However, the aggregation 
onset was observed at much smaller concentrations than what was observed in the previous 
study. The differences obtained between fluorescence emission profiles with pure labelled BAs 
and mixtures of labelled and unlabelled BAs shows increased efficiency for labelled BA 
aggregation when compared to the unlabelled species. 
The aggregation number of these aggregates is something these results cannot decipher. 
Figure 3-7 – Labelled BA fluorescence intensity emission (A, C) and anisotropy (B, D) as a function of 
concentration. Labelled BA only (closed symbol) or a 1:1 mixture of BA:Labelled BA (open symbol) were 
stepwise added to buffer and fluorescence emission spectra and anisotropy was registered. Intensity 
values obtained were corrected for inner-filter effects (Eq. 1). Labelled BAs were excited at 460 nm and 
fluorescence emission was recovered between 480-700 nm, fluorescence anisotropy was measured at 
540nm. (A, B) DCA-NBD and UDCA-NBD corrected fluorescence intensity as a function of concentration, 
respectively. (C, D) DCA-NBD and UDCA-NBDF fluorescence anisotropy as a function of concentration, 
respectively. 
A 
B 
C 
D 
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Since anisotropies are not affected by aggregation, the aggregate number is probably small. 
Considering that the formation of even-numbered aggregates of BAs is more favourable [9], the 
observed aggregates are probably made from 2 or 4 monomers. In Figure 3-9 possible BA 
aggregates are represented. For quenching to happen, the NBD group would have to be in close 
proximity with another NBD. Notice in the first dimer how the NBD groups are apart from each 
other. In the second dimer, a NBD group from one of the BA in the dimer would the in close 
proximity with a NBD group from the other BA. This might account for the fluorescence 
quenching. If it is assumed that the top terminal groups do not affect the ones on the bottom, a 
tetramer would be indistinguishable from the second dimer (Figure 3-9). This only goes to show 
that the stoichiometry of the aggregate is not accessible from our results. 
  
Figure 3-8 – Fluorescence lifetime-weighted quantum yield (A) and 
fluorescence anisotropy decays (B) of DCA-NBD and UDCA-NBD (blue and 
red, respectively) at 5 and 10 μM concentrations (closed and open circles, 
respectively). Labeled BA were excited at 340nm and emission was 
recovered at 540nm. 
A 
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3.1.3. DCA-NBD interacts with unlabelled BA 
 
One hypothesis for the cytotoxic role of DCA is its aggregation state; possibly DCA 
aggregates are toxic to cells. As well, hydrophilic BAs might create a hydrophobic:hydrophilic 
species that is less apoptotic-prone. To look for an interaction, 100 μM of UDCA and TUDCA 
were added to 2 μM of DCA-NBD. This concentration was chosen since as shown in Figure 3-7 no 
aggregation is expected for the labelled BA. Fluorescence emission intensity was recorded as a 
function of time. 
When DCA-NBD is added to buffer, its fluorescence intensity decreases slowly (Figure 
3-10). This indicates that DCA-NBD is aggregating already at 2 μM, although the decrease in 
fluorescence is only between 5 and 10%, and as such, aggregation should be very limited (see 
below). After the addition of 100 μM of hydrophilic BAs UDCA or TUDCA, the intensity of DCA-
NBD changes significantly, indicating an interaction between DCA-NBD and hydrophilic BAs. 
The formation of a DCA-NBD:UDCA aggregate leads to a decrease in fluorescence while 
the aggregate formed with TUDCA has a higher fluorescence signal. This might be explained by 
the quenching effect of the carboxyl group. When a DCA-NBD:UDCA complex is formed, the 
carboxyl group from UDCA is in proximity with the NBD group from DCA-NBD, possibly 
quenching its fluorescence. TUDCA, on the other hand, contains no carboxyl group, and the 
sulphate group is further apart from the steroid ring due to a longer side-chain. Possibly, this 
longer side chain does not affect the NBD group, bringing forth a DCA-NBD:TUDCA species that is 
more fluorescent than DCA-NBD.  
In order to test if DCA-NBD interaction with hydrophilic BAs is able to change the 
aggregation state of DCA-NBD, the aforementioned aggregation profiles for DCA-NBD were 
repeated by adding labelled DCA to a 100 μM solution of either UDCA; TUDCA or DCA. 
The presence of unlabelled BAs leads to an increase in DCA-NBD fluorescence intensity 
at concentrations of labelled BA higher than 4 μM (Figure 3-10C). This is an indication that the 
unlabelled BAs disrupt the formation of DCA-NBD aggregates to some extent. Possibly, since 
significant aggregate formation is only detected over 2 μM of labelled BA, partial disruption of 
DCA-NBD aggregate is only effective above this concentration. 
Figure 3-9 - Schematic representation of bile acid aggregates. 
Adapted from [8] 
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Figure 3-10 - DCA-NBD fluorescence intensity as a function of time in the presence 
or absence of 100 μM UDCA (A) and TUDCA (B) and aggregation profiles of DCA-
NBD in the absence or presence of unlabelled DCA, UDCA and TUDCA (C). (A, B) 2 
μM of DCA-NBD were incubated for 30min in the absence of hydrophilic BA. At 
34min, 100 μM of UDCA (A) or TUDCA (B) were added. DCA-NBD was excited at 
460nm and fluorescnce emission intensity was measured between 480-580nm, 
every 5min. Fluorescence intensisty is normalized for intensity at t=0min. (C) DCA-
NBD was stepwise added to a buffer solution without any BA (black), or containing 
100 μM of DCA (blue), or UDCA (red) or TUDCA (green). DCA-NBD was excited at 
460nm and fluorescence emission intensity was recorded from 480-700nm and 
corrected for inner-filter effects. 
A 
B 
C 
 Results 
45 
 
Aggregation model 
From these curves a simple model was developed to clarify the DCA-NBD aggregation 
state. In this model, monomeric DCA-NBD, mDCA*, can either interact with himself, aggregating 
and generating aggDCA*, or interact with unlabelled BA, forming a BA:DCA-NBD complex, BA-
DCA* (Figure 3-11, Eq. 23). 
 
Some assumptions are made in this model. First, since the exact stoichiometry of 
aggregation is unknown, the reaction mDCA*⇆aggDCA* is assumed to be a dimerization. 
Secondly, it is assumed that only monomeric DCA-NBD can interact with unlabelled BA. 
                  
                         Eq. 23 
   
To fit the model into our data, the measured fluorescence signal is assumed to be the 
sum of the signal from each constituent (Eq. 24). 
 
                          
                   
  
                 
   
Eq. 24 
   
 
DCA-NBD only 
First, the fit was made on the curve that contained only DCA-NBD. In this case no BA-
DCA* was considered so the model consisted only of DCA* aggregation (Figure 3-11). In this case 
the observed signal is defined by (Eq. 25): 
                           
                   
   Eq. 25 
   
        can be calculated through the dimerization constant (Eq. 26), with         
     
     
              (Eq. 24): 
        
         
        
 
         
                          
 Eq. 26 
   
 
  
mDCA* + Unlabeled BA 
BA-DCA* aggDCA* 
Dimerization 
Figure 3-11 - Model for DCA-NBD interactions. Monomeric DCA-NBD (mDCA*) 
can either dimerize to form aggregated DCA-NBD (aggDCA*) or interact with 
unlabelled BA to form a BA:DCA-NBD complex (BA-DCA*) 
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Solving the previous equation to         (Eq. 27): 
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Eq. 27 
   
Substituting in Eq. 24, results in (Eq. 28): 
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Eq. 28 
   
The fit (Figure 3-12A) yielded an            (Table 3-2), which indicates that the DCA* 
aggregates are non-fluorescent (dark). The model also retrieved a dimerization constant of 
          (Table 3-2). Fit was achieved through the least square methodology. Weighting for 
the inverse of DCA-NBD concentration is included to achieve a higher confidence of the fit result 
at lower concentrations. Goodness of the fit was judged by the sum of the weighted residuals. 
 
DCA, UDCA and TUDCA curves 
Now, considering the two equilibriums simultaneously (Figure 3-11, Eq. 24),         
can be calculated from each equilibria (Eq. 29, Eq. 30): 
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 Eq. 29 
   
     
         
                 
         
         
             
 Eq. 30 
   
where                   , since                
   (Eq. 30). From these 
equations we obtain (Eq. 31): 
  √
         
      
 
         
             
 Eq. 31 
   
Isolating           yields (Eq. 32): 
           
                 
   
            
 Eq. 32 
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Substituting         (Eq. 30) and           (Eq. 32) on the overall equation (Eq. 23) 
creates (Eq. 33): 
 
     
     
  
         
             
   
                 
   
            
           
Eq. 33 
   
Solving Eq. 33 to           (Eq. 34): 
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Eq. 
34 
   
The signal equation (Eq. 24) is obtained by replacing           in the following 
equation (Eq. 35): 
 
                     
         
             
          
                 
   
            
                 
   
Eq. 35 
   
This equation was fitted to the data obtained with UDCA, TUDCA and DCA (Figure 3-12B-
D). Previously determined values for       ,          and        were fixed during the fit 
procedure. Additionally, further fitting restrictions were considered, namely that             
       and                             as previously observed (Figure 3-10). 
The model retrieved small equilibrium constants for the interaction with unlabelled BAs, 
one order of magnitude lower than the DCA-NBD dimerization constant (Table 3-2). 
Table 3-2 - Parameters recovered for the interaction between DCA-NBD and other BAs. 
Species 
Interaction 
constant (μM-1) 
Ф/ФmDCA* 
mDCA* - 1 
aggDCA* 0.121 0 
DCA-DCA* 0.004 0.55 
UDCA-DCA* 0.004 0.55 
TUDCA-DCA* 0.002 1 
 
The constructed model presents one limitation, as only a dimerization step is considered 
in the aggregation of DCA-NBD, which is a simplification of the real behaviour of the molecule. 
The model retrieved an intensity signal for aggDCA* equal to zero. This would mean that the 
aggregates are dark and do not contribute to neither lifetime nor anisotropy. According to our 
previous results this is not absolutely true, suggesting a presence of a small population of 
aggregated DCA-NBD with a quantum yield higher than 0. 
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The model retrieved a DCA-NBD dimerization constant one order of magnitude higher 
than any other interaction constant. This means that DCA-NBD interacts weakly with other BA, 
including DCA. This is probably a consequence of charge neutralization in DCA-NBD, which 
removes electrostatic repulsive forces between negatively charged BAs. In this way BA-NBD are 
not ideal mimics of BA behaviour in solution, and we can assume the recovered values for DCA-
NBD/BAs dimerization constants as the upper bound limits to the DCA-BA interaction. As such, 
although DCA could exhibit similar affinities for DCA itself and hydrophobic BAs (Figure 3-10), we 
can easily conclude from the recovered equilibrium constants (with unlabelled BAs), that in the 
range of BA concentration used in apoptotic studies (around 100 μM of both apoptotic and 
antiapoptotic BAs), the fraction of DCA in hydrophobic dimers would change from 34% to 23% in 
the absence or presence of hydrophilic BAs respectively. These are the upper bounds for these 
species assuming the aggregation constant (0.004 μM-1) from Table 3-2, and as can be easily 
recognizable, this difference is not expected to translate into a significant change in BA activity. 
The main conclusion obtained from this model is that DCA is only marginally aggregated 
at apoptotic concentrations and hydrophilic BAs are not expected to dramatically change the 
fraction of DCA in hydrophobic aggregates. This would indicate that the cytoprotective role of 
hydrophilic BAs is not obtained through direct interactions with DCA in solution. 
Figure 3-12 – DCA-NBD aggregation profiles and its fits obtained with the model for DCA-NBD 
aggregation. DCA-NBD aggregation in the absence of unlabelled BAs (A), or with 100 μM of DCA 
(B) UDCA (C) and TUDCA (D). Squares represent DCA-NBD fluorescence intensity (values 
obtained in Figure 3-10) and lines represent fitted curves with proper parameters (Table 3-2). 
DCA-NBD was excited at 460 and fluorescence emission measured at 480-700m. 
A 
B 
C 
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3.2. Labelled bile acids and membranes 
 
Since the cytoprotective role of hydrophilic BAs does not appear to be associated with 
solubilisation of DCA aggregates in solution, the focus will now be on the interaction of BAs with 
lipid membranes. The first goal is to characterize and quantify BA partition to lipid membranes 
with different compositions. Also, possible effects of hydrophilic BAs on DCA-NBD membrane 
partition at submicellar concentrations will be evaluated.  
For the formation of all model membrane systems, the required amounts of POPC, Chol 
and PSM were used. The correct lipid concentrations for each lipid phase were taken from the 
phase diagram for this ternary system (Figure 3-13) [68]. 
 
3.2.1. Labelled BA partition  
 
To assess probe partition to lipid membranes, the concentration of lipid vesicles is 
varied, while labelled BA concentration is kept constant at 2 µM. Labelled BA was added to the 
lipid vesicles and left to incubate for approximately 30min after which labelled BA fluorescence 
intensity and anisotropy were measured as a function of liposome concentration. After 
obtaining the partition curves, partition coefficients values, KP, can be recovered through the 
fitting of the Eq. 13 to the data. Fitting was conducted assuming that the fluorescence emission 
signal in water was the signal obtained for [POPC] = 0, while values for KP and IL (subscript L for 
Figure 3-13 - POPC/Cholesterol/Sphingomyelin phase diagram at 23ºC. The 
coloured circles represent experimental conditions. Blue circle represents 100% 
POPC, which is in the liquid disordered (ld) phase. Orange circle represents liquid 
ordered (lo)–only vesicles, corresponding to the lo phase. Red and green circles 
represents cholesterol-rich  lipososmes and GUV composition, respectively, located 
in the region of ld and lo phase coexistence. Circle coordinates (POPC:Chol:PSM 
relative concentrations) are 100:0:0, 60:40:0, 33:33:33 and 25:35:40 for blue, red, 
green and orange circles respectively. 
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lipid) were obtained by the least-squared methodology. KP values for membrane/water partition 
correspond to a quantified evaluation on the affinity of a particular molecule for lipid 
membranes. The affinity for lipid membranes is of great relevance in determining the 
pharmacological effects of a number of drugs [69]. In order to analyse membrane partition 
behaviour of fluorescently labelled BAs, three systems will be used. Firstly, partition to POPC-
only vesicles will be assessed. Then partition to lo-only vesicles will be quantified. To 
complement the aforementioned studies, imaging of DCA-NBD and UDCA-NBD in GUVs with lo 
and ld phase coexistence will be conducted. 
 
Labelled BA partition to POPC vesicles 
Labelled BA fluorescence intensity and fluorescence anisotropy increased as a function 
of lipid concentration for both labelled BAs (Figure 3-14). This is accompanied by a blue-shift in 
the emission spectra of both probes (Figure 3-15). 
Recovered partitions coefficients were similar for both labelled BAs (Table 3-3). KP from 
anisotropy curves were one fourth of KP obtained from intensities. The apparent contradiction 
between these KP’s can be explained by the existence of Homo-FRET. When NBD molecules are 
sufficiently close, energy transfer can occur between them. This does not result in an intensity 
decrease, because molecules are identical, but in an anisotropy decrease, since the donor and 
acceptor molecules would have different positions in the membrane and their emission 
momentum would be oriented differently, leading to a less polarized emission. For high KP’s, 
when POPC concentration is low, fluorophore density in membrane is very high. This would lead 
to an increase in Homo-FRET, which would decrease as POPC concentration increases. This effect 
would lower anisotropy values at low POPC concentrations and would wear off for high POPC 
concentrations. Hence, through the anisotropy curve, labelled BA partition is underestimated, 
and for this reason, KP’s were always obtained from steady-state fluorescence intensities. 
The anisotropy decays when lipid concentration is highest are significantly different from 
anisotropy decays obtained only in buffer (Figure 3-8, Figure 3-16). Namely, the fluorophore 
does not depolarize completely, hinting that its motion is hindered by the membrane. This 
means that the fluorophore does not possess a spherical, complete, liberty of motion but can 
only move in a restricted volume. This dynamics was modelled by Kinosita as a wobbling-in-cone 
[70]. In this model, rotation of this molecule beyond the limits of this cone is assumed to be 
energetically impossible. The opening, or angle, of the cone can be retrieved from the anisotropy 
decays through (Eq. 36): 
     ⁄  [
 
 
                      ]
 
 Eq. 36 
   
where    is the limiting anisotropy value,    is the anisotropy at time 0 ns and       the 
value of the cone angle. Values vary between 0° (     , no rotation during the excited state) 
to 90° (    , complete depolarization during the excited state). Results obtained for DCA- and 
UDCA-NBD are identical, 63° and 64°, respectively (Table 3-3) and suggest that both molecules 
present a very similar location within the lipid membranes. Additionally, and comparing to the 
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published values of NBD cone angles for rotation (36-50º) obtained for a phospholipid anchored 
NBD (NBD-DPPE) also in ld bilayers [71], it can be concluded that the labelled BAs are still 
significantly mobile. This means that NBD groups are possibly not anchored within the acyl-
chains, since this would result in significantly lower rotational dynamics as seen for NBD-DPPE. 
These values can be compared since the average lifetimes obtained for DCA-NBD and UDCA-NBD 
are almost identical to the    of NBD-DPPE in the same study (6.1-7.1 ns) [71]. 
Figure 3-14 - Fluorescence intensity (A) and anisotropy (B) for DCA-NBD (blue) and 
UDCA-NBD (red) as a function of POPC concentration. Experimental points are 
displayed as squares (intensities, A) and circles (anisotropies, B). Fits are displayed 
by curves (same colour code) using the KP values shown in the legend. Labelled BAs 
were excited at 460nm; fluorescence intensities were measured between 480-
700nm and anisotropy was measured at 540nm. 2 μM of DCA-NBD were used. 
Fluorescence intensity values were normalized to the value at [POPC] = 0 μM. 
A 
B 
Results 
52 
 
Figure 3-15 – Fluorescence emission spectra of DCA-NBD (A) and UDCA-NBD (B) 
shift to lower wavelengths when POPC concentration increases. POPC 
concrentration is indicated by the tendency arrow. Labelled BAs were excited at 
460nm; fluorescence intensities were measured between 480-700nm and 
anisotropy was measured at 540nm. 
A 
B 
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Labelled BA partition to Chol-rich vesicles 
Next, the partition of labelled BAs was assessed to liposomes with a composition of 
POPC, Chol and PSM so that only a liquid ordered (lo) phase is formed (Figure 3-13). This phase is 
characterized by a lower degree of acyl-chain dynamics and similar lateral diffusion as the liquid 
disordered phase [68]. 
Labelled BA fluorescence intensity and anisotropy increase as a function of lipid 
concentration for both labelled BAs (Figure 3-17). This is accompanied by a blue-shift in the 
emission spectra of both probes (results not shown). 
For lo vesicles, DCA-NBD partitions more effectively than UDCA-NBD. This is evident in 
the partition curves (Figure 3-17) and recovered parameters (Table 3-3). The KP obtained from 
anisotropies in this experiment are much more alike the KP from intensities. This is due to a 
lower partition and hence lower NBD densities for low lipid concentration. In these conditions, 
energy migration is no longer significant and partition curves present identical shapes for both 
anisotropies and fluorescence intensities. 
Figure 3-16 - Fluorescence anisotropy decays of DCA-NBD (blue) and UDCA-
NBD (red) in POPC vesicles. 2 μM of labelled BAs were added to POPC 
vesicles, were excited at 340nm and fluorescence anisotropy was recovered 
at 540nm. 
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Figure 3-17 – Fluorescence emission intensity (A) and anisotropy (B) for DCA-NBD 
(blue) and UDCA-NBD (red) as a function of lipid concentration. Experimental 
points are displayed as squares (intensities, A) and circles (anisotropies, B). Fits are 
displayed by curves (same colour code) using the KP values in legend. Labelled BAs 
were excited at 460nm, fluorescence intensities were measured between 480-
700nm and anisotropy was measured at 540nm. 2 μM of DCA-NBD were used, and 
lo vesicles were formed using 25% POPC: 35% Chol: 40% PSM (mol/mol). 
Fluorescence intensity values were normalized to the value at [Lipid] = 0 μM. 
A 
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Comparing partitions, KP(ld,lo) 
Having a KP for ld and another for lo, a KP(ld,lo) can be calculated. This KP(ld,lo), is the ratio 
between KP(ld) and KP(lo), and reflects the relative affinity of labelled BAs to the ld and lo lipid 
membrane phases (Eq. 37). For this calculation it was assumed that labelled BA would partition 
equally to POPC-only-ld phase and a POPC:Chol:SM-ld phase. 
           
      
      
 Eq. 37 
   
The obtained KP(ld,lo) shows that if there is phase coexistence, labelled BA would 
preferably partition to the ld phase (Table 3-3). This is in agreement with previous results, that 
showed that taurine-conjugated BA partition less to Chol-rich membranes and also that the most 
hydrophobic BAs were less affected by higher membrane order [46]. 
One interesting result is that the fluorescence anisotropy of both labelled BAs in the lipid 
membrane is similar for both ld and lo membrane phases (Table 3-3). The main distinction 
between ld and lo phase is their rigidity, being lo the more rigid of the two. It appears that the 
rotational dynamics of the NBD group is insensitive to rigidity of the phase they are partitioning 
to. This suggests that the NBD group in BA-NBD is not on the inside of the membrane but at the 
lipid/water interface. 
 
Table 3-3 – Partition coefficients and labelled BA fluorescence lifetimes, steady-state anisotropies and rotation cone 
angles (according to [70] in lipid membranes. 
Labelled BA 
Lipid 
phase 
KP (10
3) KP(ld,lo) <r>L θ (⁰)  ̅L (ns) 
  L  
(ns) 
DCA-NBD 
ld 53.9±7.7 5.5±1.0 
0.15 63 5.4 6.6 
lo 9.7±1.1 0.14 - - - 
UDCA-NBD 
ld 40.9±6.3 9.1±2.2 0.14 64 5.3 6.7 
lo 4.5±0.8  0.16 - - - 
 
To have a better appreciation of the different partition to ld and lo phase, GUVs with 
phase coexistence were electroformed. In this way, the preferable partition of labelled BA can 
be observed. In this experiment, Rhodamine-DOPE (Rho-DOPE, Table 2-1) was used to label the 
ld phase within the GUVs. The lo phase within the GUVs could not be labelled since this typically 
requires NBD-DPPE, which would interfere with the signal from NBD-labelled BA.  
GUV z-stack images were taken to construct 2D maximum intensity projections (Figure 
3-18). Since GUVs are spherical, 2D projections appear as a circle. lo phase is unlabelled and 
shows up as dark regions in the projection. 
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Once again, a clear ld preference is observed as the signal from the NBD channel co-
localizes with the signal from the Rhodamine channel (Figure 3-18). The overlay is merely a 
superimposition of images from both channels and is meant to serve as a guide. 
 
ITC experiments 
When constructing a fluorescent derivate of a molecule, the main concern is to lessen 
the disturbance in the original molecule. The ld preferable partition of labelled BA is a signal that 
the driving force behind partition is not the NBD group but the biliary domain of the molecule. 
Rho Channel NBD Channel Overlay 
No BA added 
+ DCA-NBD 
+ UDCA-NBD 
Figure 3-18 - Maximum intensity projections of Rho-DOPE labelled GUVs incubated with or without DCA-NBD or 
UDCA-NBD. Immobilized GUVs (composition POPC:Chol:PSM 1:1:1 (mol/mol/mol) were labelled with Rho-DOPE 
at a ratio of 1/500, biotinylated lipid DPPE-biotin was included at total lipid ration of 1/10
6
. Fluorescence from 
Rho (red) and NBD (green) channel was sequentially collected and projections for the entire GUV are shown for 
GUVs in the absence of labelled BAs (A) or in the presence of 20 μM of DCA-NBD (B) and UDCA-NBD (C). Overlay 
is simply a superimposition of the Rho and NBD channel and is meant to serve as a guide. 
A 
C 
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Isothermal titration calorimetry was thought to be able to measure the partition of both 
labelled and unlabelled BAs. However, BA partition to model membranes is a process that does 
not release a significant amount of heat. A signal could not be measured until BA concentration 
was raised to millimolar levels. In this regime, vesicle interaction became noticeable but the 
registered signal could not be related to partition. In normal ITC studies of partition, exothermic 
spikes are registered [66], while in this experiment, with 1 mM of DCA, endothermic spikes were 
observed (Figure 3-19). This is not a partition event and is most likely associated with 
disassembly of aggregated DCA dissolution upon membrane binding. This result is indicative that 
BAs bind to lipid membranes mostly through adsorption rather than incorporation in acyl-chains, 
since the latter is expected to be highly exothermic [66].  
 
Conclusions 
These results show that labelled BAs efficiently interact with membranes, while both 
hydrophobic and hydrophilic BAs exhibited preferential partition to ld phase in the presence of lo 
domains. However, DCA-NBD partition coefficient to the lo phase is two times larger than the KP 
for UDCA-NBD. Additionally, since NBD anisotropy is practically the same in ld and lo, a superficial 
location for the fluorophore is assumed. 
Figure 3-19 – Titration of DCA (1 mM) with LUVs composed of POPC (20 
mM) in buffer. (A) Obtained thermogram was integrated to yield the heat 
of reaction for each injection (B). Experiment was performed by titrating 10 
μL aliquots of liposomes into a BA solution in the sample cell. 
A 
B 
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From the ITC experiment, it can be understood that BA partition to membranes is a low-
energy event, possibly associated with an adsorption of BAs to the bilayer rather than insertion 
in the membrane interior. The differential affinity of labelled BAS to lipid membranes depending 
on the lipid phase would then be associated with different packing densities at the membrane 
surface, which could modulate BA adsorption. 
The high partition coefficients determined for the labelled BAs in the liquid disordered 
phase reinforces the idea that BA actions could be based on membrane altering effects. In 
apoptotic assays, DCA concentration is typically at 100 μM. In the case of total partition of the 
BA to the plasma membrane, a very high density of DCA is expected at the membrane surface 
with possible consequences for membrane structure. This will be the subject of the studies 
presented in Section 3.3. 
 
3.2.2. The effect of hydrophilic bile acid on DCA-NBD partition 
 
One possible mechanism for the cytoprotective role of hydrophilic BAs would be the 
prevention of DCA partition to lipid membranes, preventing hydrophobic BA effects on 
membranes. To test for this effect, DCA-NBD partition to POPC vesicles was assessed after 
vesicles were incubated overnight with hydrophilic BAs. 2 µM of DCA-NBD were then added to 
the vesicles and DCA-NBD partition was assessed by fluorescence intensity, anisotropy and 
lifetime. Two concentrations of hydrophilic BA were used, 10 and 100 µM. 
DCA-NBD partition seems to be unaffected by previous vesicle incubation with 
hydrophilic BAs as fluorescence lifetime partition curves obtained are independent of 
hydrophilic BA concentration (Figure 3-20). Although the recovered KP values vary from the 
control value, these are always within error. Also, anisotropy decays obtained using the highest 
POPC concentration were independent of hydrophilic BA concentration. 
This result clearly proves that neither UDCA nor TUDCA have an effect on DCA-NBD 
partition to lipid membranes. 
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Figure 3-20 – DCA-NBD fluorescence lifetime-weighted quantum yield as a function of POPC 
concentration, and DCA-NBD fluorescence anisotropy decays at the highest POPC concentrations for 
several hydrophilic BA concentrations. (A, C) DCA-NBD fluorescence lifetime-weighted quantum yields 
Experimental data and fits are displayed as symbols and lines respectively. Blue line and symbols when no 
hydrophilic BA is added and red or green for incubation with UDCA or TUDCA, respectively. Closed and 
open symbols refer to incubation with 10 or 100 μM incubation with unlabelled BA, respectively. DCA-
NBD was excited at 340nm and fluorescence emission decays were obtained at 540nm. 
A 
B 
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3.3. Unlabelled bile acids and labelled-liposomes 
 
Previously, it was shown that hydrophilic BA interaction with DCA was very limited and 
did not affect its partition to POPC membranes. However, it is possible that both hydrophobic 
and hydrophilic BAs affect membrane biophysical parameters in opposing ways. One might 
hypothesize that besides apoptosis being triggered by a direct effect of hydrophobic BAs on the 
lipid bilayer, the observed cytoprotective effect of hydrophilic BAs could be associated with a 
direct influence on the biophysical properties of the lipid membrane. After this effect, the 
membrane becomes DCA-insensitive and apoptosis would not triggered. 
In order to test for specific effects of BAs on membrane biophysical properties, several 
standard membrane probes will be used, each probing for one membrane biophysical 
parameters (Table 2-1). 
 
3.3.1. Bile acid location on model membrane systems 
 
Firstly, DPH and TMA-DPH were used. Both fluorescent probes are widely used to report 
membrane fluidity as their fluorescence anisotropy is extremely sensitive to membrane 
composition and order [58,68]. Three different lipid mixtures were used: only POPC; 60:40 
POPC:Chol (mol/mol); and 33:33:33% POPC:PSM:Chol (mol/mol/mol) (Figure 3-13). Preformed 
liposomes were incubated overnight with up to 100 μM of DCA, UDCA and TUDCA. DPH and 
TMA-DPH anisotropy was measured as a function of BA concentration. 
No fluorescence anisotropy variation is observed for both DPH and TMA-DPH (Figure 
3-21). One possible explanation for the absence of membrane perturbation by unlabelled BAs 
would be a lower partition coefficient for these species than what was previously calculated for 
labelled versions (Table 3-3). Importantly, the studies with unlabelled BAs were conducted at a 
very high concentration (100 μM), while partition studies with labelled BAs were performed at 2 
μM. These two concentrations are likely to correspond to completely different aggregation 
states for the molecule, and BAs, when added to liposomes at high concentrations, do not 
associate as monomers (as already observed from ITC data, Figure 3-19). In this case, these 
aggregates do not fully dissociate after association with the lipid membrane, consequently, 
effects on the lipid membrane will be mainly local, and a large fraction of the membrane will 
remain unperturbed. Alternatively, the aggregation of BAs might stabilize the fraction of BAs not 
associated with lipid membranes, decreasing membrane/water partition coefficients. Both of 
these phenomena are able to explain the absence of membrane perturbation by BAs added to 
preformed liposomes. 
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Figure 3-21 - DPH (A) and TMA-DPH (B) fluorescence anisotropy as a function of BA 
concentrations for various lipid compositions. 100 μM of DPH-labelled (A) or TMA-
DPH-labelled (B) lipid vesicles containing either only POPC (full lines and symbols), 
33:33:33 POPC:Chol:PSM (mol/mol/mol) (dashed lines and half-open symbols) or 
60:40 POPC:Chol (mol/mol) (dotted line and open symbols) were incubated 
overnight with either DCA (blue) or TUDCA (green). Both probes were excited at 
340nm and fluorescence anisotropy was measured at 430nm. Probe/lipid ratio 
used was 1/200. 
A 
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Figure 3-22 - DPH (A) and TMA-DPH (B) fluorescence anisotropy in POPC vesicles as 
a function of BA concentrations for various preparation methodologies. 100 μM of 
DPH-labelled (A) or TMA-DPH-labelled (B) lipid vesicles containing only POPC were 
incubated overnight with various DCA or TUDCA concentrations (dashed lines and 
open symbols, blue and green respectively, called “POPC with…”). 100 μM of DPH-
labelled (A) or TMA-DPH-labelled (B) lipid vesicles containing only POPC were 
cosolubilized with various DCA, TUDCA and UDCA concentrations (full lines and 
closed symbols, blue, green and red respectively, called “POPC +…”). Both probes 
were excited at 340nm and fluorescence anisotropy was measured at 430nm. 
Probe/lipid ratio used was 1/200. 
A 
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To confirm that the absence of membrane partition was caused by BA aggregation in 
solution, BAs were cosolubilized with lipids and membrane probes before liposomes formation. 
The advantage of cosolubilization is that added components are immediately solubilized by lipids 
and aggregates are not formed in solution. Using this methodology with POPC liposomes, DPH 
and TMA-DPH fluorescence anisotropy was measured as a function of BA concentration. 
DPH anisotropy continues to be insensitive to all BAs (Figure 3-22A). However, TMA-DPH 
anisotropy increases significantly when BAs are cosolubilized along with the liposomes (Figure 
3-22B). Insensitivity of DPH and sensitivity of TMA-DPH to cosolubilized BAs indicates that BAs 
are found only at the membrane surface, and acyl chain fluidity is unaltered.  
To confirm a superficial location of BAs on the membrane, another membrane probe 
was used. Di-4-ANEPPDHQ is sensitive to membrane potential [72,73]. BAs were added to 
preformed ANEPPDHQ-labelled liposomes or cosolubilized with membrane components. 
When BAs are added to preformed liposomes labelled with ANEPPDHQ, no fluorescence 
intensity variation is seen (Figure 3-23), as had been previously observed for DPH and TMA-DPH 
(Figure 3-21). However, when DCA is cosolubilized with the liposomes, ANEPPDHQ fluorescent 
intensity varies significantly (Figure 3-23). 
Clearly, BAs are in fact aggregating when added to preformed liposomes. These 
aggregates either partition less than monomers or remain stable after membrane association, 
affecting the membrane surface only locally. It is highly likely, that in vivo, the presence of a 
Figure 3-23 - ANEPPDHQ fluorescence intensity as a function of BA concentration, 
added to preformed POPC liposomes and incubated overnight (dashed lines and 
open symbols) or cosolubilized with liposomes (full lines and closed symbols). DCA, 
UDCA and TUDCA are represented as blue, red and green, respectively. ANEPPDHQ 
was excited at 470nm and fluorescence emission was measured at 500-800nm. 
Probe/lipid ratio used was 1/200. 
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large concentration of proteins and different membrane components contribute to the 
solubilisation of these aggregates, and effective partition to membranes is in this way achieved. 
Since partition of BAs in vitro is limited by aggregation of the molecules before 
membrane interaction, higher concentrations of BAs were used to probe for modulation of 
membrane biophysical properties. In this way, BA concentration was raised to 500 μM while 
keeping lipid concentration at 200 μM. Unlabelled BAs were then added to preformed liposomes 
labelled with ANEPPDHQ and its lifetime was measured. However, at such high concentrations of 
BAs, membrane solubilisation cannot be discarded. To test for this unwanted effect, DPH-
labelled liposomes were subjected to the same treatment as ANEPPDHQ liposomes. 
It was observed that ANEPPDHQ lifetime increases significantly when liposomes were 
incubated with all BAs (Figure 3-24A). The increase was greater when DCA was added, in 
agreement with previous results (Figure 3-23). However, both hydrophilic BAs also increased the 
membrane probe fluorescence lifetime. This is a clear sign of interaction between BAs and 
liposomes. 
Since DCA and hydrophilic BAs produced different effects on ANEPPDHQ lifetime, a co-
incubation of liposomes with hydrophilic BA + DCA (500 + 500 μM) was performed. Hydrophilic 
BAs and DCA were added simultaneously. 
When liposomes were incubated with both DCA and hydrophilic BAs, ANEPPDHQ 
lifetime increases in a cumulative way, so that after co-incubation, differences in fluorescence 
lifetimes were the sum of the effects of DCA plus the hydrophilic BA used (Figure 3-24A). When 
UDCA was added, fluorescence lifetime increased by 0.085 ns and when DCA is added, 
fluorescence lifetime increased by 0.185 ns. Incubation with both resulted in a fluorescence 
lifetime increase of 0.27 ns (equal to 0.085 + 0.185). In this way, hydrophilic BAs do not prevent 
DCA-induced changes on ANEPPDHQ fluorescence.  
These results (Figure 3-24A) could potentially be explained by membrane solubilisation 
or intercalation by BAs at these high concentrations. Noticeably, ANEPPDHQ fluorescence 
anisotropy decays are insensitive to the presence of BAs (Figure 3-24B). On the other hand, DPH 
fluorescence anisotropy in the presence of the high BA concentration is only slightly affected 
and decreased by 10% (Figure 3-24C). This decrease is very small and cannot be associated with 
vesicle solubilisation, as DPH in micelles typically presents fluorescence anisotropy values of 
0.10-0.12 [74–76]. In fact, the decrease in DPH anisotropy is at least partially associated with an 
increase in DPH lifetime. This would allow for a longer depolarization time, which would lower 
anisotropy [61]. 
Overall, these results clearly indicate that liposomes were still intact after BA treatment, 
and that both environments which ANEPPDHQ and DPH are probing remain almost dynamically 
unchanged in every experimental condition. Since BAs are unable to intercalate between lipids 
and to induce membrane solubilisation at 500 μM, the increase in fluorescence lifetime 
observed for ANEPPDHQ is likely associated with a decrease in membrane hydration due to high 
levels of BA partition. 
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Figure 3-24 - ANEPPDHQ fluorescence lifetime-weighted quantum yield (A) and 
fluorescence anisotropy decay (B) and DPH anisotropy (C) in POPC liposomes after 
incubation with 500 μM of BA or 500 DCA + 500 μM hydrophilic BAs. (A, B) 500 μM of BAs 
were incubated overnight with ANEPPDHQ-labelled liposomes. No BA (black), 500 μM of 
DCA, UDCA or TUDCA (blue, red or green, respectively) or 500 + 500 μM of DCA plus UDCA 
or TUDCA (light blue and pink in (A) and open red and green  in (B), respectively) were 
added to liposomes. ANEPPDHQ was excited at 460nm and emission was recovered at 
590nm. (C) DCA, UDCA or TUDCA (blue, red, green, respectively) were added to POPC 
liposomes and incubated overnight. DPH was excited at 340nm and fluorescence 
anisotropy was recovered at 430nm. Probe/lipid ratio used was 1/200 
A 
B 
C 
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In summary, TMA-DPH and ANEPPDHQ are clearly sensitive to cosolubilized BAs, 
particularly DCA. Considering that DPH is located in the membrane interior and that both TMA-
DPH and ANEPPDHQ are located in the membrane surface, the putative location of BA is on the 
membrane surface (Figure 3-25). These results are in full agreement with data obtained for 
labelled BAs. 
  
3.3.2. The effect of Chol on bile acids 
 
Several papers have been written on the role of Chol in the interaction between BAs and 
vesicles. Some suggested that BAs and Chol compete for the same position in the membrane 
[46,47] while others showed BA depend on membrane Chol to exert their role in vivo [54]. Here, 
the effect of BAs on membrane biophysical properties was assessed using several Chol mixtures 
of POPC:Chol (Figure 3-26). DPH was used to label the liposomes and its steady-state anisotropy 
Figure 3-26 - POPC:Chol phase diagram. Mixtures with 
100:0, 95:5, 90:10, 85:15, 80:20 and 60:40 POPC:Chol 
(mol/mol) were used. According to the lever rule, POPC:Chol 
mixtures are constituted by 9, 24 and 82% lo when the 
fraction of Chol is 15, 20 and 40%, respectively. 
Figure 3-25 - Schematic representation of membrane probe and possible BA location in the 
membrane. Phospholipids in dark blue, DPH in light blue, TMA-DPH in yellow and 
ANEPPDHQ in red. BAs are displayed as grey/white/black molecules. 
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was measured as a function of Chol concentration. 
As Chol content is increased, DPH anisotropy values also increased, suggesting a tighter 
packing of the lipids in the membrane (Figure 3-27A). Liposome incubation with either UDCA or 
TUDCA did not induce any change in DPH anisotropy (Figure 3-27A). 
However, when DCA was added, DPH anisotropy decreased significantly (Figure 3-27A). 
Membrane fluidity was only sensitive to DCA when Chol was present and was larger for 20% 
Figure 3-27 - DPH fluorescence anisotropy as a function of Chol concentration for 
different BA incubated overnight. DPH labelled liposomes were incubated 
overnight with 100 or 500 µM of DCA (open blue, closed blue symbols, 
respectively) or 500 µM of UDCA and TUDCA alone (closed red and green symbols, 
respectively) or 500 µM of UDCA or TUDCA followed 8h of 500 µM of DCA 
incubation (open red and green symbols, respectively). Liposomes are composed of 
POPC:Chol at 100:0, 95:5, 90:10, 85:15, 80:20, 60:40 (mol/mol). DPH was excited at 
340nm and fluorescence emission measured at 430nm. Probe/lipid ratio used was 
1/200. 
A 
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Chol. When liposomes with 80:20 POPC:Chol (mol/mol) liposomes are incubated with DCA, DPH 
anisotropy is the equal to the value with 90:10 POPC:Chol (mol/mol) control liposomes (no BA 
incubation). At 40% Chol, DPH anisotropy increased, approaching values obtained for the 
control. In this way, considering that the latter composition of corresponds almost to 100% lo 
phase, DCA is inert for lo membranes but inhibits the rigidifying effect of Chol in ld phases. This 
effect cannot be associated only by a decrease in lo domain formation since it is observed at Chol 
concentrations for which the lo phase is not formed (5 and 10% Chol, Figure 3-26). 
For this effect to occur, high concentrations of DCA are needed since 100 μM of DCA 
produces near-control values for DPH anisotropy (Figure 3-27B). Also, co-incubation of vesicles 
with UDCA or TUDCA plus DCA does not prevent the effect of DCA (Figure 3-27B). 
One possible explanation for this effect is that BAs remove Chol from membranes, since 
significant changes in membrane fluidity are only observed in the presence of Chol.  
To test if membrane fluidity changes in the presence of DCA were due to Chol 
sequestration from the membrane, a fluorescent Chol analogue, dehydroergosterol (DHE) was 
used [77–79]. Unlike other fluorescent sterols [80], the behaviour of this molecule in lipid 
membranes has great similarity to Chol [79]. POPC-only liposomes labelled with DHE were 
incubated overnight with 100 μM of DCA, 500 μM of DCA, UDCA or TUDCA. Coincubations with 
hydrophilic BAs plus DCA were also performed. As a control, DHE (in the absence of liposomes) 
was also added to 500 μM of DCA to register the signal of complete DHE removal. DHE 
fluorescence in 500 μM of DCA (in the absence of liposomes) is nearly 10% of its value in 
vesicles, indicating that removal could be followed by intensity variations (Figure 3-28). 
However, when BAs were added to membranes, no loss in fluorescence intensity was observed. 
This means that no BA can remove DHE from liposomes, which indicates that DCA is not 
removing membrane Chol. 
A decrease in DPH fluorescence anisotropy induced by DCA could be caused by an 
increase in the lifetime by DPH. With this in mind, both fluorescence intensity and fluorescence 
anisotropy decays of DPH were obtained from liposomes with 0, 20 and 40% Chol after 
incubation with 500 μM DCA. 
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Clearly, DPH lifetime were not affected by DCA incubation in the presence of Chol 
(Figure 3-29A). However, DCA is noticeably interfering with the rotational dynamic of DPH, 
affecting both the rotation cone angles [70] (Figure 3-29B) and the anisotropy decay of DPH 
(Figure 3-29C). The fluorescence anisotropy decay of DPH with 20% Chol and 500 μM DCA is 
almost identical to the decay obtained with 0% Chol in the absence of BA incubation. 
  
Figure 3-28 - Dehydroergosterol fluorescence intensity in liposomes incubated with 
and without 500 µM BA. DHE labelled liposomes were incubated with 500 µM of 
BA overnight. DHE was added to 500 µM solution of only DCA and incubated 
overnight. DHE was excited at 280nm and fluorescence intensity measured at 
320nm. Probe/lipid ratio used was 1/200 
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FRET experiment 
It was shown that DCA can dramatically affect the biophysical properties of Chol 
containing membranes. It is possible that DCA is in fact changing the phase diagram of the 
POPC:Chol mixture and altering the formation of ld and lo domains. 
Firstly, a simple experiment was devised: GUVs containing 58% lo phase were formed. An 
immobilized GUV was selected and imaged before and after BA addition. In this experiment, 
Rhodamine-DOPE (Rho-DOPE) was used to label the ld phase within the GUVs and NBD-DPPE to 
label the lo phase within the GUVs (Table 2-1). GUV z-stack images were taken to construct 2D 
maximum intensity projections to assess domain size and distribution. 
After the addition of 500 μM of DCA no noticeable changes in domain size was observed 
(Figure 3-30). Noticeably, during incubation with DCA, the ld domain, labelled red, shifted to the 
bottom hemisphere of the GUV and the proportion of ld in the GUV increased from 40% in the 
Figure 3-29 - Average lifetimes (A), cone angles according to [70] (B) and anisotropy decays of DPH 
as a function of membrane Chol content in the absence or presence of 500 μM of DCA. DPH 
labelled liposomes were incubated overnight without any BA (control) or with 500 µM of DCA. 
DPH was excited at 340nm and fluorescence intensity was measured at 430nm. Probe/lipid ratio 
used was 1/200. 
A B 
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absence of DCA to 44% in the presence of DCA. This increase in ld percentage is within error of 
the measurement. In this way, if DCA induces changes in the phase diagram of POPC:Chol:PSM 
they are very subtle and this methodology lacks the resolution to detect them. 
To probe for domain size redistribution below the resolution limit of the confocal 
microscope, a FRET experiment was devised. Lipid domain sizes at the nanometer scale can be 
assessed through a FRET experiment. Using as FRET pairs Rho-DOPE (acceptor) and NBD-DPPE 
(donor), measured FRET efficiency can be related to domain size. These two labelled 
phospholipids exhibit completely distinct partition behaviour in lipid membranes with ld and lo 
phase coexistence. FRET between the two molecules is dramatically reduced when large 
domains are formed, as FRET events between NBD-molecules in the lo phase and Rho-DOPE 
species in the ld phase become irrelevant. However, for small sized domains (below 75 nm for 
this FRET pair), FRET events between the two lipid phases become more frequent and FRET 
efficiencies increase as the average domain size decreases up to 20 nm, when FRET efficiencies 
are undistinguishable from a homogeneous mixture [81]. 
Making use of the theoretical model for FRET efficiency between donor and acceptor in 
two planes (as the headgroup regions of each monolayer can be considered) it is possible to 
determine both the FRET efficiency for the case of a homogeneous distribution of donors and 
Figure 3-30 – Projections of the same GUV before (A, B) and after (C, D) 500 μM DCA incubation. GUV 
with POPC:Chol:PSM 45.1:25:29.9 (mol/mol/mol), 58% lo, was labelled with Rho-DOPE and NBD-DPPE 
at a ratio of 1/500 and 1/200 respectively, biotinylated lipid DPPE-biotin was included at a ratio to 
total lipid of 1/10
6
 to achieve immobilization. Immobilized GUV was imaged before and after addition 
of 500 μM of DCA. Fluorescence from Rho (red) and NBD (green) channel was sequentially collected 
and projections for the top and bottom hemisphere of the GUV are shown for GUVs in the absence (A 
bottom, B top) and presence (C bottom, D top) of DCA. 
After 500 μM of DCA 
Bottom 
hemisphere 
Top 
hemisphere 
Before DCA addition 
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acceptors (no domains or domain size < 20nm) and the case of infinite phase separation 
(domains > 75nm) (Eq. 18-Eq. 20). Using this methodology, de Almeida and coworkers [74], 
followed changes in domains sizes along a tie-line, within the ld/lo phase coexistence region of 
the phase diagram for the POPC:Chol:PSM mixture. These authors found that lo domains are very 
small (< 20nm) for low lo fractions and increased in size for higher lo content [74]. 
Here, that study is reproduced with the same lipid mixture after incubation with BAs. 5 
different lipid compositions were chosen so that liposomes with 0, 26, 58, 86 and 100% of lo 
phase were obtained (Table 3-4). Liposomes were labelled either with NBD-DPPE (donor) or with 
both NBD-DPPE and Rho-DOPE (donor + acceptor). These were either incubated overnight in the 
absence (control) or in the presence of 500 μM DCA. Fluorescence intensity emission spectra 
and donor fluorescence lifetime were measured as a function of % lo. FRET efficiencies were 
calculated using donor lifetime variation (Eq. 17) 
The calculated FRET efficiencies are always higher for the control group than for 
liposomes incubated with DCA (Figure 3-31). In this system, a decrease in FRET efficiencies can 
be attributed to 3 possible causes: i) decrease in donor quantum yield; ii) changes in domain 
sizes; iii) increase in total surface area.  
A decrease in donor quantum yield results in lower    values (Eq. 15), and hence lower 
FRET efficiencies. In fact, a 10% decrease in the quantum yield of NBD-DPPE in 0% lo is observed 
after DCA incubation (Table 3-4). From Eq. 15, this decrease results in a decrease of the    for 
Rho-NBD FRET pair from 50 Å (in the absence of DCA) to 49 Å. According to Eq. 18, Eq. 19 and 
Eq. 20, for a random distribution of donors and acceptors, these Förster radii would lead to FRET 
efficiency values of 0.60 and 0.58, respectively. Additionally, quenching of NBD-DPPE is less 
effective for the remaining lipid compositions (Table 3-4). Clearly, the decrease in donor 
quantum yield, although relevant, is not responsible for the decrease in FRET efficiencies after 
DCA incubation. 
Table 3-4 – Composition of lipid mixtures used in the FRET experiment, % lo formed and effect of DCA on NBD-DPPE 
lifetime 
%POPC 
(mol) 
%Chol 
(mol) 
%PSM 
(mol) 
% lo 
 ̅   
 ̅       
⁄  of NBD-
DPPE without acceptor 
71.6 5 23.3 0 0,90 
59.7 14 26.3 26 0,96 
45.1 25 29.9 58 0,96 
34 33.3 32.7 86 0,95 
25.4 39.8 34.8 100 1,01 
 
Concerning changes in domain size, it seems unlikely the DCA has any effect. DCA 
reduces FRET efficiencies for every lipid mixture in the tie-line, including when no phase 
separation is expected to occur, 0% ld or 100% lo. Additionally, FRET efficiencies also decrease 
after DCA incubation in POPC only liposomes where phase separation does not occur (Figure 
3-31). 
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In this way, and by elimination of alternatives, the increase in membrane surface area by 
BA binding to the membrane is the most likely interpretation for the FRET data. After DCA 
interaction with the membrane surface, it can intercalate with the headgroups of the lipids and 
separate them, expanding the membrane. In this way, every lipid would be further apart from 
each other, including acceptors, and FRET efficiency would decrease in a non-specific manner. A 
25% increase in lipid area would justify the decrease in FRET efficiency for 0% lo. This increase in 
membrane area might help explain previous observations of increase in membrane permeability 
after BA treatment [47,49]. 
The theoretical FRET efficiency expected for a homogeneous lipid mixture (0.60) is not 
observed at 100% lo, a phenomena previously observed [74,75]. The likely reason for this 
behaviour is that Rho-DOPE, the acceptor, aggregates in the lo phase, leading to the formation of 
Rho-DOPE clusters. The formation of these clusters would decrease the probability of FRET 
Figure 3-31 - FRET efficiencies for various lo proportions incubated in the absence 
(control) or in the presence of 500 μM of DCA. Liposome composition followed a 
tie-line described in the ternary phase diagram for POPC:Chol:PSM (Figure 3-13, 
Table 3-4). NBD-DPPE or NBD-DPPE and Rho-DOPE labelled liposomes were excited 
at 480 and fluorescence emission was recovered at 530nm (A) or between 460-
530nm (B). FRET efficiencies were calculated according to Eq. 17 
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events due to a decrease in the fraction of donors with an acceptor in their vicinity. 
Surprisingly, a change in FRET efficiency is also observed at 100% lo, suggesting an 
interaction between BAs and the membrane. However, in the lo, phase the FRET model is no 
longer able to explain the data (even in the absence of BAs), as significantly larger FRET 
efficiencies are expected. As already discussed, Rho-DOPE is heavily clustered and acceptor 
densities can no longer be determined assuming a homogeneous distribution of membrane 
components. In these conditions, the observed effects could also be induced by acceptor 
extraction. Given that all data points to an absence of BA partition to the lo phase, an artefact 
associated with acceptor distribution is likely to be responsible for the FRET decrease at high lo 
content. 
To discard an effect induced by DCA at 100% lo, DPH anisotropy in a 100% lo liposome 
was measured. The mixture was then heated to induce a change the lipid phase, from lo to ld. 
With heating, lipids in the system gain energy, the ordered phase cannot be maintained and 
domains of ld phase start to form [81]. 
No change in DPH anisotropy at room temperature (only lo phase formed) was measured 
(Figure 3-32). Additionally, when liposomes are heated to 55°C (disruption of lo, formation of 
some ld), DCA induced a decrease in the fluorescence anisotropy of DPH. This is consistent with 
previous results and further shows that DCA can affect ld phases with different compositions and 
is inert for different lo compositions. Liposomes were then cooled down to 35°C, to test the 
reversibility of the effect. DPH fluorescence anisotropy returns to values (Figure 3-32) obtained 
before, indicating a loss of effect, due to the formation of the lo phase. This confirms that the 
phenomena observed is reversible and is an additional confirmation that the effect of DCA is not 
associated with a removal of Chol from the membrane, as this process would not be expected to 
Figure 3-32 - DPH fluorescence anisotropy as a function of temperature. 
DPH labelled liposomes were incubated in the absence (black circles) or 
presence of 500 μM of DCA (blue circles). Liposomes were composed of 
25.4:39.8:34.8 POPC:Chol:PSM (mol/mol/mol) so as to form only the lo 
phase at room temperature. Liposomes were heated to different 
temperatures and fluorescence anisotropy was measured. After 55°C 
(closed circles), liposomes were cooled down back to 35°C (open circles). 
Probe/lipid ratio was 1/200. 
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be reversible. 
To summarize, DCA appears to make ld membranes insensitive to the presence of Chol. 
This effect is not mitigated by hydrophilic BAs and is not achieved through the removal of Chol 
from lipid membranes. Also, it is not observed for different lo rich-membranes. This effect cannot 
be associated only with a decrease in lo domain formation, since it is observed at Chol 
concentrations for which the lo phase is not formed. In this way, the adsorption of DCA to ld 
membranes directly inhibits the rigidification effect of Chol on the bilayer. However, upon lo 
formation this inhibition is no longer observed, possibly due to a significant loss of DCA in the 
membrane, as determined for the fluorescent labelled BAs partition. 
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3.4. Bile acid effect on live HEK293 cells 
 
To conclude this thesis, some experiments were conducted on live HEK293 cells. The 
only criteria for choosing this cell line was the simplicity of culture. The susceptibility of the cell 
line to apoptosis was secondary, and the focus was on the direct effect of BAs on the lipid 
membrane. 
Two experiments were conducted with this cell line.  
Firstly, cells were incubated with DCA-NBD and UDCA-NBD for 30min and fluorescence 
intensity and location was assessed under the microscope. DCA-NBD distribution was also 
evaluated after HEK293 cells were pre-incubated with 100 μM TUDCA for 30min. 
Both DCA-NBD and UDCA-NBD fluorescence was localized almost everywhere in the cell, 
except for the nucleus (Figure 3-33). These labelled BA are probably traversing the membrane 
and partitioning to every membrane in the cell. The fluorescence distribution of DCA-NBD was 
unaffected by TUDCA pre-incubation (Figure 3-33). 
Having seen that labelled BAs distribute equally on HEK293 cells, the effects of 
unlabelled BA were studied using ANEPPDHQ as a membrane probe. Cells were incubated with 
the membrane probe for 30min, followed by 30min incubation with either 50 or 100 μM of 
TUDCA or DCA. Cells incubated with 100 μM of TUDCA were incubated for another 30min with 
50 μM of DCA. ANEPPDHQ lifetime was measured using FLIM. 
Surprisingly ANEPPDHQ lifetime decreased when BAs were added to HEK293 cells 
(Figure 3-34). This is in contradiction to our previous results in model systems, when an increase 
in ANEPPDHQ lifetime was observed (Figure 3-24). However, previous results were obtained 
using only POPC liposomes. Importantly, even for the control experiment, where no BA was 
added, ANEPPDHQ lifetime was larger than in control experiment using POPC vesicles. When 
DCA was added after TUDCA, the decrease in lifetime was not so pronounced. A decrease in 
ANEPPDHQ lifetime would probably mean the probe is more exposed to the solvent, suggesting 
a higher degree of membrane hydration. 
Figure 3-33 - Location of labelled BA on HEK293 cells. HEK293 cells were incubated for 30min 
with 10 μM of labelled BAs, followed by a 30min preincubation with 100 μM TUDCA in the case 
of TUDCA+DCA-NBD. Cells were imaged on confocal microscope using NBD fluorescence. 
DCA-NBD 
A 
TUDCA + DCA-NBD 
B 
UDCA-NBD 
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ANEPPDHQ is labelling every cellular membrane and the obtained fluorescence decay is 
the sum of individual decays from all the cellular membranes: plasma membrane, Golgi 
reticulum, nucleus, etc. Taking into account the partition behaviour observed for fluorescently 
labelled BAs, it is highly likely that BAs bind differently to the membrane of each organelle 
depending on the Chol content. In this case, the effect of BAs on membrane structure might 
change significantly from organelle to organelle. As such, in order to correctly interpret data 
from living cells, a more detailed analysis is required to quantify the effects of BAs in the 
membrane of each organelle individually. 
 
 
 
Figure 3-34 - ANEPPDHQ fluorescence lifetimes as a function of added BA. 
HEK293 cells labelled with 10 μM of ANEPPDHQ were incubated with 50 or 
100 μM of DCA or TUDCA for 30min. Additionally, a co-incubation was 
performed with 100 μM TUDCA + 50 μM DCA for 30+30min. ANEPPDHQ 
was imaged using FLIM, to recover fluorescence decays. 
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Firstly, labelled BAs can detect micelles formed by unlabelled BAs. CMC values recovered 
with BA-NBD were in range of values previously described in the literature. BA-NBD probes 
demonstrated high affinity for BA aggregates. 
Both DCA-NBD and UDCA-NBD aggregate at submicellar concentrations, and both prefer 
to form homodimers but can also interact with unlabelled BAs. The recovered equilibrium 
constants for DCA-NBD interaction with different BAs can be considered as the upper bounds for 
DCA interaction with the same BAs, since unlabelled BAs experience electrostatic repulsion 
which is absent for DCA-NBD containing aggregates. Still, even considering these upper bounds 
for the efficiency of DCA interaction with hydrophilic BAs, incubation with hydrophilic BAs is not 
expected to change the fraction of aggregated DCA in a dramatic manner. These results allow us 
to discard the solubilisation of DCA as a possible mechanism through which hydrophilic BAs 
could exert a cytoprotective effect. 
 
Secondly, labelled BA partition was assessed and observed to be dependent on the level 
of order in the membrane. The difference between membrane partition efficiencies observed for 
hydrophobic and hydrophilic BAs is significant and on the cholesterol-rich plasma membrane is 
expected to result in a different effective concentrations of these two species. It is possible that 
this could dictate the apoptotic potential of hydrophobic BAs and the absence of the effect with 
hydrophilic BAs. As discussed before, the labelling of DCA and UDCA with NBD, removing the 
carboxylic acid, might generate a molecule more favourable to partition to lipid membranes. For 
the negatively charged BAs, partition to lipid membranes at high densities might be severely 
hindered due to increases in membrane surface charge. 
Other results also show that the cytoprotective role of hydrophilic BA is not achieved 
through the prevention of hydrophobic BA partition. The partition of DCA-NBD to lipid 
membranes was completely insensitive to UDCA incubation, and although high densities of 
unlabelled UDCA and TUDCA at the membrane might interfere significantly with DCA partition 
given the resulting increase of membrane surface charge, we observed that these hydrophilic 
BAs were not able to inhibit the effects of DCA on the membrane structure (as seen for 
membrane fluorescent probes), even at very high concentrations. Partition results for the 
derivatized BAs with liquid ordered membranes clearly indicate that UDCA-NBD was significantly 
less prone for membrane interaction when compared with DCA-NBD in such membrane 
environments. This lower membrane partition observed for hydrophilic BAs might help explain 
why UDCA and TUDCA were unable to inhibit DCA partition and ultimately could be the reason 
why these molecules are generally not inducers of apoptosis. As such, the hypothesis of a shield 
of UDCA and TUDCA over the membranes as the basis for its cytoprotective effect is rejected. 
 
Finally, the results obtained with membrane probes clearly showed that BAs interact 
with lipid membranes. This interaction is superficial as ANEPPDHQ and TMA-DPH are sensitive to 
it, while DPH, which probes the membrane interior, is much less sensitive to the presence of 
BAs. In this way, BAs bind lipid membranes mostly through adsorption rather than incorporation 
in acyl-chains as previously suggested [47,48,51]. 
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Another important result is that unlabelled BAs are aggregated when added to 
preformed liposomes, and this aggregation is likely preventing membrane partition of BAs to 
model membranes. As already discussed, the presence of a large concentration of proteins and 
different membrane components in vivo would contribute to solubilize these aggregates, and 
effective partition to membranes is in this way achieved. 
Interaction of hydrophobic BAs with lipid membranes in the liquid disordered phase 
resulted in a significant increase in membrane surface area, indicative of significant partition of 
BAs to the membrane. This effect might be related to changes in membrane permeability 
observed after incubation of both isolated mitochondria and model membranes with 
hydrophobic BAs [47,48]. 
Surprisingly, DCA was able to disrupt to some extent the ordering of the membrane by 
Chol. This property was particularly strong at low Chol concentrations, corresponding to no or 
low fractions of lo phase. At higher Chol content, when lo comprises most of the membrane area, 
the ability of DCA to disorder the membrane was significantly reduced. Taking into account the 
partition behaviour of fluorescently labelled BAs, it can be concluded that the absence of effects 
on the lo phase is due to an absence of membrane binding by BAs to lo membranes. In this way, it 
is possible that the apoptotic effect of BAs could also be achieved through changes in membrane 
structure or modulation of membrane composition. As discussed before, lipid rafts are essential 
checkpoints for apoptotic signalling [21,26] and disturbance of this homeostasis, for example 
caused by Chol deprivation, can lead to apoptosis [19,45]. 
Also, a recent paper reported that the oligomerization of Bax in model membrane 
systems was dependent on its fluidity, increasing the Chol content of the membrane inhibited 
Bax insertion [82]. One possible mechanism of DCA-induced apoptosis can be the prevention of 
mitochondrial membrane rigidification, rendering it susceptible to Bax oligomerizatio and 
further damage. 
Importantly, the effect of DCA on order of Chol containing membranes could not be 
countered by co-incubation with hydrophilic BAs. In fact, these molecules also induced some 
degree of disordering in Chol containing membranes, albeit a much smaller one than DCA. The 
coincubation of lipid membranes with both hydrophobic and hydrophilic BAs resulted in a 
cumulative effect on the membrane order. As already discussed, it is likely that the reason why 
hydrophilic BAs are not apoptotic in hepatocytes while DCA is strongly apoptotic, at the same 
concentrations, is associated with differential affinities for lipid membranes for the two classes 
of BAs. Conversely, the cytoprotective role of hydrophilic BAs might not be related to the direct 
modulation of membrane structure, and cytoprotection could be achieved through direct 
activation of a survival signal [28,33,83]. 
 
In summary, the mechanism through which hydrophilic BAs prevent activation of 
apoptosis of hydrophobic BAs is neither the formation of BA complexes in solution, prevention 
of hydrophobic BA partition to membranes, nor the inhibition of membrane perturbations by 
hydrophobic BAs. However, it is shown here that hydrophobic BAs might act by modifying 
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membrane structure and/or increasing permeability. Possibly, the effects of hydrophobic BAs on 
the plasma membrane could result in changes in membrane raft composition. 
Future work devoted to this topic will pursue the effect of BAs on the mitochondrial 
membrane. Partition studies as well as probing for changes in mitochondrial membrane 
biophysical properties will be conducted in order to elucidate the effect of BAs on mitochondrial 
stress. Also, the effect of BAs on membranes in vivo will be the subject of a more in-depth study. 
In Figure 4-1 a cartoon depicts DCA interacting with a lipid membrane consisting of a lo 
domain in a ld matrix. The BAs partition to the ld phase expanding, increase the area it occupies. 
 
 
  
l
d
 phase 
without DCA 
Lipid raft 
(lo phase) 
l
d
 phase 
with DCA 
Figure 4-1 - Cartoon depicting DCA interactions with a generic lipid membrane with lo and ld phase coexistence. ld 
and lo phases are shown in green and red tones, respectively. DCA (purple) exhibits a superficial location in the 
membrane after binding and partitions preferably to the ld phase. Additionally, the ld phase to which DCA 
partitions to is expanded due to interaction with the hydrophobic BA. 
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